rfhg_34641.1

Basic information about the TSS

---

TSS ID: rfhg_34641.1 Species: human Chr: chr2		Start: 170929131 End: 170929141 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3208054,EH38E2050702)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000444801.5:56 GeneID: 26003 HGNC/MGI_ID: HGNC:17500 UniProt_ID: F8WEG2 Nearer transcript ids and distances: AK315508:84 AK023201:100 ENST00000497674.5:112 ENST00000493692.5:112 ENST00000234160.5:112 NM_015530.5:112 AK293640:112 AK225810:112 AK023082:113 ENST00000455067.5:116 ENST00000454751.5:126 AK298020:131 BC007770:151 BC001408:158 ENST00000442798.5:180 AK296698:180 AK027349:186 AB528359:196 DQ895965:198 DQ892715:198 CU675801:199 KJ893507:199 ENST00000497928.1:292 view more...

Gene_name: golgi reassembly stacking protein 2 Gene_symbol: GORASP2 Gene_synonyms: GOLPH6 GRASP55 GRS2 Gene_source: HGNC:17500

TATA-Box annotation

---

Distance to TSS:	-117
Nearest PromoterID:	NM_015530
Entrez ID:	26003
Nearest Unigene:	Hs.431317
Nearest Refseq:	NM_015530
Nearest Ensembl:	ENSG00000115806
Gene Name:	golgi reassembly stacking protein 2
Gene Alias:	GOLPH6|GRASP55|GRS2|p59
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.636364
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GORASP2 p2@GORASP2 p3@GORASP2 p4@GORASP2 p5@GORASP2 p7@GORASP2 p8@GORASP2
Sample		p1@GORASP2	p2@GORASP2	p3@GORASP2	p4@GORASP2	p5@GORASP2	p7@GORASP2	p8@GORASP2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	75.58	1.75	4.09	2.14	2.14	2.14	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	77.29	1.01	2.83	2.43	1.42	1.82	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	71.18	1.74	4.05	2.70	1.54	2.70	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	62.17	0.62	2.29	2.08	1.04	2.70	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	70.86	1.57	3.37	1.35	1.35	3.15	2.02
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	64.93	2.13	3.10	2.91	1.16	2.13	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	86.50	1.31	4.36	1.53	2.18	2.18	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	75.57	1.21	3.88	1.94	1.94	3.15	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	75.66	1.92	2.56	2.56	1.50	2.78	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	58.54	2.32	2.32	1.74	1.16	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	67.10	1.62	1.62	1.21	1.21	0.40	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	71.96	0.81	2.85	1.63	1.22	1.22	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	35.95	1.45	2.90	0.16	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	39.84	2.56	2.56	0.15	1.35	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	33.15	3.29	4.61	0.44	1.10	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	36.47	3.02	2.26	0.00	0.75	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.45	2.62	2.84	0.44	0.66	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	32.90	1.69	3.37	0.00	1.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	29.32	2.67	4.80	0.00	1.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	31.14	2.71	3.01	0.15	0.60	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	37.16	2.94	3.21	0.27	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	37.98	2.76	2.76	0.35	1.38	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	34.51	3.62	3.10	0.78	0.65	0.26	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	34.94	3.15	1.70	0.24	0.24	0.24	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	30.96	4.39	2.58	0.26	0.77	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	26.90	2.85	3.80	0.00	2.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.42	2.20	4.95	0.00	1.65	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	43.14	2.83	4.24	0.00	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	28.43	2.75	3.07	0.48	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	38.91	2.90	2.53	0.72	0.90	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.82	1.67	3.98	1.26	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	31.85	2.54	2.34	0.20	0.59	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	30.81	3.59	3.38	0.21	1.27	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.67	4.12	3.13	0.99	1.65	0.33	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	35.72	3.74	2.62	0.37	0.75	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	40.43	3.45	4.02	0.77	0.19	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	35.56	4.09	3.07	0.00	1.23	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	33.45	4.03	3.02	0.40	1.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	33.76	2.97	2.97	0.00	1.08	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	38.65	3.12	3.84	0.96	0.72	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	37.64	4.00	2.59	0.47	1.88	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	34.55	2.93	3.81	0.15	0.44	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	38.17	2.74	3.80	0.00	1.27	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	37.76	2.97	3.85	0.70	0.87	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.54	2.61	4.42	0.60	1.41	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	38.85	3.26	3.02	0.70	2.33	0.23	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	37.67	5.52	2.64	0.96	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	37.85	5.36	2.68	1.19	1.19	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	47.87	4.79	5.51	0.96	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	39.23	4.65	3.24	0.61	1.01	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	50.42	6.97	5.94	0.82	1.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	73.16	9.56	5.34	0.67	2.45	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	279.84	41.98	27.98	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	60.33	7.81	6.03	0.35	3.90	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	72.57	10.27	4.97	0.99	3.98	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	93.12	8.39	14.26	1.68	15.10	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	77.15	11.48	8.73	0.46	2.30	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	87.19	5.83	6.81	0.32	1.30	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	80.61	8.67	6.74	0.64	2.57	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	86.44	6.60	10.37	0.63	4.71	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	59.93	8.46	6.35	0.71	2.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	47.11	1.68	2.24	0.56	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	88.37	3.98	11.15	0.00	5.57	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	61.50	4.42	5.10	0.00	1.70	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	66.61	3.57	3.57	0.00	2.27	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	68.16	3.55	4.26	0.00	2.13	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	173.74	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	65.33	7.31	1.95	0.00	0.98	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	64.46	5.45	1.98	0.00	0.99	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	71.31	5.16	0.47	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	71.87	4.31	3.97	0.00	1.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	63.11	5.26	3.71	0.31	1.86	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	66.35	3.97	3.06	0.31	0.92	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	71.27	7.76	5.54	0.32	0.95	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	65.29	6.10	4.65	0.80	2.09	0.32	0.64
Adipocyte - omental, donor1	11473-119C6	103.69	12.85	7.89	1.40	1.15	0.38	0.64
Adipocyte - omental, donor2	11474-119C7	71.01	7.47	1.49	0.00	2.24	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	64.97	5.02	4.02	0.33	1.34	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	82.30	6.38	3.83	1.28	1.91	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	28.59	2.20	2.20	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	65.94	6.32	4.52	0.45	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	48.31	2.78	4.00	1.22	0.00	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	94.66	8.80	4.11	1.56	0.20	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	49.67	3.35	2.32	1.03	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	57.15	4.46	3.35	0.28	0.28	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	39.38	4.70	1.18	1.18	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	77.14	8.12	4.50	1.13	0.64	0.72	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	47.44	4.52	1.94	1.29	0.97	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	44.25	3.20	2.67	1.07	3.20	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	43.40	0.56	3.90	1.11	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	48.24	4.57	2.91	0.42	0.42	0.83	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	41.69	2.76	3.01	1.00	0.50	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	41.23	4.58	5.24	0.33	0.65	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	30.14	4.87	1.52	0.30	0.61	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	104.53	3.54	5.52	0.66	0.66	1.10	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	56.30	2.87	1.08	1.43	0.72	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	46.72	3.59	3.59	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	91.93	4.14	3.06	1.08	0.54	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	58.57	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	85.26	2.47	1.64	1.03	1.03	0.00	0.82
Anulus Pulposus Cell, donor1	11248-116E6	74.03	4.00	5.03	1.14	1.37	0.11	0.23
Anulus Pulposus Cell, donor2	11463-119B5	54.86	3.18	3.18	1.47	0.24	0.24	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	51.22	3.59	4.04	1.35	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	58.61	2.60	1.74	0.43	2.60	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	64.21	0.00	6.42	0.00	6.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	51.71	2.39	4.48	1.79	3.89	0.30	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	69.56	2.53	6.32	0.00	1.26	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	39.60	3.30	1.98	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	56.21	1.62	4.22	2.27	1.62	0.32	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	56.80	5.83	4.37	0.49	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	47.51	1.78	3.56	1.19	3.56	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	57.63	3.01	2.26	1.51	1.13	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	56.60	3.63	1.45	0.00	3.63	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	35.11	0.00	3.76	0.00	3.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	57.66	3.29	5.93	0.99	0.82	0.82	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	50.50	5.46	8.19	2.73	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	45.39	2.87	2.56	1.06	0.75	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	60.01	4.29	4.29	1.07	2.68	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	52.90	3.78	3.97	0.76	1.70	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	55.60	4.54	3.21	1.07	1.34	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	47.80	3.90	3.90	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	56.89	3.15	1.82	1.33	1.66	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	43.23	1.20	3.60	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	67.26	0.00	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	57.63	3.60	4.46	1.37	1.20	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	4.19	4.19	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	50.00	4.37	5.34	0.00	2.43	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	63.37	3.04	4.17	0.76	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	64.20	2.42	4.85	0.00	4.85	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	53.58	1.71	2.85	0.57	2.28	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	58.57	2.57	4.92	1.07	0.86	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	41.29	3.87	2.84	0.00	1.81	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	60.53	5.63	3.28	1.41	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	50.48	2.57	3.86	1.29	1.29	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	40.67	2.14	2.14	0.00	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	63.17	1.17	2.34	0.58	1.17	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	52.69	3.61	3.91	0.00	0.30	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	43.96	1.19	2.38	1.19	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	54.92	4.58	3.05	0.51	3.05	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	56.03	3.06	2.55	0.76	2.80	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	41.93	2.54	3.81	1.27	3.18	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	56.96	1.73	3.02	0.86	1.73	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	53.34	2.33	3.18	1.06	2.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	35.67	2.32	2.03	0.00	1.45	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	40.62	2.83	2.83	0.00	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	51.54	2.20	3.56	1.02	0.68	0.68	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	4.63	4.63	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	61.26	4.23	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	62.61	5.79	3.00	1.50	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	51.14	2.41	4.21	0.00	1.80	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	43.74	2.92	1.46	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	60.46	2.30	4.14	0.92	1.84	0.92	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	45.91	7.65	7.65	0.00	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	57.71	2.29	4.83	1.02	1.02	0.76	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	66.89	5.78	4.75	1.03	1.45	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	49.27	2.45	4.90	1.22	1.84	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	62.62	4.30	6.69	2.39	2.87	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	58.54	3.10	2.22	1.77	1.33	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	59.51	1.53	6.10	0.00	3.05	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	53.17	4.43	3.32	0.00	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	55.34	2.91	4.50	1.06	2.91	1.59	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	49.79	3.63	2.54	0.36	1.09	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	94.57	4.79	3.81	1.72	0.61	0.98	0.61
Astrocyte - cerebellum, donor2	11580-120F5	69.83	4.62	2.74	0.86	0.34	0.86	0.00
Astrocyte - cerebellum, donor3	11661-122F5	59.99	3.99	1.89	0.42	0.63	0.63	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	72.16	4.53	3.14	1.39	1.05	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	73.61	4.04	2.10	1.13	1.13	0.97	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	80.84	4.77	1.19	0.75	1.94	0.45	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	142.21	9.17	5.16	1.49	2.64	0.80	1.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	161.24	9.65	5.76	2.76	1.25	1.75	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	149.53	8.42	5.92	1.93	1.14	2.16	0.91
Basophils, donor1	12241-129G9	31.12	2.62	3.40	0.52	0.52	0.26	0.52
Basophils, donor2	12242-129H1	68.91	6.13	3.97	1.08	0.00	0.72	0.72
Basophils, donor3	12243-129H2	46.89	4.85	3.38	0.59	0.15	0.15	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	59.51	5.39	4.31	0.43	0.86	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	31.09	4.11	1.37	0.46	0.00	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	0.00	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	57.74	2.51	1.88	0.63	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	55.73	2.29	2.29	0.42	1.25	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	64.94	5.07	1.84	0.69	0.00	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	54.34	2.70	2.34	1.08	0.00	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	88.83	6.18	5.98	1.13	1.13	0.72	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	112.96	10.71	5.36	1.40	0.70	0.70	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	64.59	7.67	5.44	3.20	0.32	0.64	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	124.10	0.00	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	37.19	3.94	3.94	2.25	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	28.21	2.60	5.01	0.56	0.93	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	32.27	2.85	3.73	0.66	1.10	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	54.06	8.21	5.09	0.28	0.00	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	56.86	9.86	3.03	0.76	0.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	49.31	7.89	5.92	0.66	0.99	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	27.90	8.67	6.79	0.14	0.43	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	35.61	6.34	5.43	0.30	0.30	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	34.11	7.82	5.69	0.00	0.24	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.41	4.69	4.02	0.00	0.50	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	19.32	3.31	4.14	0.28	0.28	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	23.80	4.71	3.72	0.74	0.50	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.29	1.96	2.15	0.20	0.00	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.56	2.31	1.78	0.18	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	24.37	5.01	4.79	0.65	0.65	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.47	1.87	3.51	0.00	0.47	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	20.07	4.22	5.28	0.53	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	19.97	3.33	5.55	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	22.91	4.31	5.50	0.30	0.45	0.30	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	24.94	3.79	5.19	0.20	0.40	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	23.73	6.25	3.54	0.62	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	13.04	2.97	2.97	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.00	2.71	2.94	0.00	0.68	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	16.59	4.36	3.93	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	22.60	6.19	4.03	0.27	0.81	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	29.31	4.54	5.41	0.00	0.87	0.52	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	35.77	6.31	8.00	0.42	0.42	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.39	1.10	2.20	0.00	0.55	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	13.39	1.06	0.70	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	19.74	3.07	1.32	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.43	2.79	1.74	0.35	0.52	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	19.70	1.86	2.60	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	25.22	3.88	3.02	0.65	0.43	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.33	2.87	1.64	0.82	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	17.85	0.93	2.32	0.46	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.40	3.48	2.09	0.00	0.23	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	32.48	3.71	4.58	0.65	0.44	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	27.95	4.16	3.46	0.00	0.92	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	23.83	3.25	2.82	0.22	0.87	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	36.91	8.88	5.76	0.47	0.93	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	32.13	9.26	5.41	0.52	0.70	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	52.84	10.93	7.80	0.89	0.67	0.67	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	21.69	3.06	1.79	0.26	0.26	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	24.59	3.95	3.07	0.88	0.66	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	33.48	2.74	2.32	0.21	0.63	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	10.16	4.06	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	46.10	10.17	4.75	0.68	0.68	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	44.53	3.11	3.11	0.00	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	59.70	4.26	5.33	0.00	0.53	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	65.40	9.11	2.14	0.00	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	61.77	7.72	2.11	0.00	1.40	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	47.85	10.20	3.92	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	61.96	7.91	1.32	0.00	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	50.96	4.93	1.64	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	57.31	2.90	2.18	0.73	2.18	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	52.00	5.05	6.56	0.50	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	40.81	3.23	2.42	0.40	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	30.36	2.80	0.80	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	24.10	6.02	4.02	2.01	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	44.38	6.18	5.06	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	60.87	5.64	4.13	0.38	0.00	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	66.74	9.24	4.06	0.90	0.45	0.45	0.23
CD4+ T Cells, donor1	11225-116C1	118.90	5.00	3.57	3.93	0.71	0.36	1.79
CD4+ T Cells, donor2	11306-117C1	86.34	4.90	2.45	2.45	4.29	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	93.63	5.79	5.18	0.91	1.22	0.30	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	64.32	8.93	3.83	0.26	0.26	0.00	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	76.81	5.39	1.57	1.12	0.45	0.00	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	71.00	5.46	2.87	1.15	0.29	0.57	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	85.34	1.90	1.90	0.47	0.95	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	68.83	5.62	3.51	3.51	0.70	0.70	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	59.33	0.00	6.59	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	64.02	10.84	6.79	0.58	1.01	0.29	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	61.01	6.27	3.90	1.19	1.69	0.00	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	52.88	7.58	2.42	0.32	1.13	0.16	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	60.52	3.59	3.59	2.69	0.90	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	63.94	5.94	1.40	0.70	2.10	1.05	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	76.56	3.52	3.08	3.08	0.44	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	72.94	10.96	5.48	0.84	0.84	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	57.97	8.52	4.16	1.04	0.42	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	51.46	7.02	5.35	0.67	2.34	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	84.84	7.89	3.81	0.27	1.36	0.27	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	101.29	4.29	3.75	0.00	0.54	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	98.63	5.38	5.38	0.00	3.59	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	86.59	7.60	6.68	1.30	0.74	0.37	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	79.28	8.88	5.20	0.65	0.65	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	78.18	9.04	2.73	1.47	1.05	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	62.69	8.60	3.03	1.52	0.51	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	71.05	6.50	4.33	0.00	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	102.42	5.23	4.36	1.31	1.74	1.31	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	106.40	9.40	4.95	1.48	0.99	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	74.78	5.54	1.85	0.92	0.92	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	75.37	11.17	1.40	0.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	101.08	6.92	3.32	1.38	0.83	0.83	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	128.34	9.32	3.44	1.23	0.25	0.49	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	104.72	4.62	3.08	1.54	1.54	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	98.48	10.03	4.30	1.79	1.07	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	113.57	8.31	1.38	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	119.17	7.86	4.26	1.96	2.62	1.31	1.31
CD8+ T Cells, donor2	11307-117C2	88.60	5.63	3.00	1.50	2.63	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	102.51	4.80	3.79	1.01	0.25	0.50	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	44.27	9.63	5.05	1.38	1.38	0.46	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	41.94	7.91	4.79	0.96	2.16	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	34.47	5.47	6.29	0.55	1.09	0.55	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	46.23	6.60	7.21	1.20	0.60	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	47.04	8.64	3.36	0.24	0.48	0.96	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	45.48	8.41	4.32	0.68	0.91	0.68	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	35.63	2.82	6.08	0.43	0.87	0.00	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	33.16	2.63	4.21	0.00	1.58	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	39.16	5.39	4.22	0.47	0.70	0.47	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	38.04	6.94	7.85	0.60	0.60	0.30	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	36.02	6.97	6.10	0.29	0.87	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	42.63	7.99	4.26	0.80	0.27	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	27.58	1.75	4.38	0.44	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	24.14	2.73	3.64	0.91	0.00	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	19.39	2.98	1.49	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	42.14	8.64	6.48	0.36	0.72	1.80	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	42.30	4.32	6.62	1.73	0.29	0.58	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	34.41	8.72	5.89	0.47	0.71	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	39.30	6.34	8.24	0.00	1.27	0.63	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	38.45	7.38	5.23	0.62	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	42.96	7.37	4.49	0.96	0.00	0.96	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	35.95	4.97	2.29	0.76	1.15	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	42.56	6.31	3.55	0.79	0.39	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	30.26	3.78	7.56	0.76	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.10	4.01	1.61	2.41	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	27.98	2.10	3.50	0.00	0.00	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	42.07	2.00	7.01	0.00	0.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	63.97	1.83	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	48.42	1.48	3.46	0.49	1.48	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	79.45	4.42	2.42	0.74	0.63	0.63	0.21
Chondrocyte - de diff, donor1	11261-116G1	84.59	9.01	4.85	0.69	0.35	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	63.61	7.46	2.49	0.36	0.36	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	60.42	6.94	8.08	0.80	1.59	0.57	0.11
Chondrocyte - re diff, donor2	11339-117F7	170.99	20.59	20.59	0.00	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	81.69	5.66	5.66	1.62	1.62	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	75.86	4.48	3.33	0.80	1.15	0.92	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	67.12	5.77	4.28	0.64	2.35	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	82.66	5.66	5.13	1.33	1.42	0.62	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	79.50	7.89	5.23	2.29	0.83	1.47	0.73
Corneal Epithelial Cells, donor1	11526-119I5	64.55	3.07	2.42	0.66	0.44	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	42.09	3.41	1.14	1.14	2.28	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	57.26	4.09	2.56	0.51	0.77	0.26	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	42.76	9.74	4.79	0.99	0.50	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	35.64	9.46	5.05	1.26	0.95	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	58.66	13.80	13.80	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	34.45	10.26	6.05	0.43	0.86	0.22	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	135.63	11.27	13.67	1.71	0.68	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	126.00	10.45	11.75	1.96	0.00	0.65	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	140.34	11.13	9.68	0.97	0.97	0.97	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	77.05	4.84	3.67	0.83	0.17	0.67	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	62.79	0.59	1.17	1.17	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	87.67	3.96	2.55	1.13	0.85	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	60.16	3.54	5.90	0.39	0.00	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	56.14	1.75	2.04	0.87	0.29	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	77.41	2.35	3.76	0.94	1.88	0.94	0.47
Endothelial Cells - Artery, donor3	11413-118E9	84.15	4.21	2.28	2.10	0.35	0.18	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	68.71	3.55	2.44	0.66	0.44	0.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	87.93	4.87	2.43	2.43	1.22	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	93.31	3.95	4.79	0.56	1.13	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	50.81	2.97	1.78	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	69.25	1.56	2.60	0.00	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	43.67	3.26	1.99	0.43	0.85	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	108.43	6.40	5.60	1.20	0.80	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	68.14	2.62	1.57	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	116.17	3.98	4.85	1.12	1.24	0.37	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	59.10	3.04	2.39	0.65	1.09	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	73.03	3.91	1.95	0.98	1.59	0.12	0.24
Endothelial Cells - Vein, donor1	11267-116G7	46.64	4.55	2.28	0.00	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	55.88	4.19	3.49	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	75.83	2.98	2.67	0.94	0.47	0.31	0.47
Eosinophils, donor1	12244-129H3	45.74	0.00	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	23.10	3.30	1.65	0.00	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	61.08	4.40	2.69	0.24	0.00	0.73	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	52.00	8.32	0.00	2.08	2.08	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	96.06	9.03	5.75	0.00	3.28	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	36.57	1.86	3.61	0.99	2.19	0.33	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	45.18	3.03	2.17	0.22	2.60	0.33	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	90.96	5.94	4.12	1.82	1.70	0.12	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	68.65	4.37	3.82	0.82	0.27	0.82	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	73.09	5.91	3.69	0.63	1.48	0.21	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	78.78	5.01	2.11	0.53	1.05	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	83.05	6.64	4.65	1.33	0.66	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	65.78	2.72	4.99	0.45	3.18	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	87.92	10.61	4.55	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	64.98	4.10	2.68	0.79	0.32	0.00	0.32
Fibroblast - Cardiac, donor4	11452-119A3	100.33	10.31	7.58	1.52	0.00	0.30	0.61
Fibroblast - Cardiac, donor5	11456-119A7	65.74	4.70	2.79	0.89	0.51	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	57.76	3.34	1.06	1.06	0.15	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	134.66	8.44	3.75	0.94	0.13	0.94	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	90.17	4.31	3.88	0.43	1.29	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	87.89	4.39	0.00	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	160.29	4.84	4.84	1.15	0.23	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	75.47	5.77	8.99	1.19	1.02	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	50.24	2.58	0.94	0.47	0.70	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	82.07	3.77	1.42	0.00	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	56.57	2.78	2.30	0.60	0.97	0.24	0.24
Fibroblast - Dermal, donor4	11450-119A1	69.64	2.15	1.58	0.57	0.68	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	79.38	3.66	2.44	0.52	0.52	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	95.99	3.57	3.90	1.14	1.14	0.49	0.32
Fibroblast - Gingival, donor1	11237-116D4	79.13	4.58	3.54	1.87	0.62	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	73.88	5.50	6.55	0.26	0.79	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	86.19	3.29	2.11	1.05	1.45	0.40	0.00
Fibroblast - Gingival, donor3	11394-118C8	89.24	4.16	4.74	1.35	0.39	0.48	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	70.64	8.31	6.23	1.04	1.04	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	57.44	3.52	1.06	0.35	1.59	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	86.83	7.79	4.83	1.56	0.47	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	71.94	6.22	3.92	1.89	1.49	0.41	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	70.93	7.76	4.94	1.76	0.00	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	81.60	5.41	5.85	1.17	1.32	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	89.04	6.14	4.77	1.23	0.55	1.23	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	91.81	8.67	5.92	1.10	0.88	0.22	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	70.29	5.43	4.84	1.17	1.03	0.15	0.15
Fibroblast - Lung, donor1	11270-116H1	36.70	1.36	1.36	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	79.08	1.49	2.98	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	73.86	4.22	2.53	0.63	0.84	0.63	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	240.74	13.33	6.66	3.33	1.67	1.67	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	96.51	4.20	2.80	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	46.46	1.68	1.40	0.56	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	257.79	15.83	9.34	2.84	0.81	1.62	0.41
Fibroblast - Mammary, donor2	11620-122A9	59.91	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	101.26	5.96	11.91	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	103.00	5.04	2.13	1.16	0.58	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	119.37	4.70	2.58	0.91	1.37	0.46	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	158.81	11.93	2.75	1.84	0.31	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	61.44	4.96	2.67	0.00	0.38	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	62.37	6.75	4.59	0.00	1.89	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	64.13	5.57	4.41	0.23	0.46	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	72.18	4.75	3.76	1.22	0.88	0.44	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	187.14	9.35	4.06	2.03	0.20	1.22	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	72.83	3.34	6.01	0.67	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	54.56	4.74	1.98	1.19	0.40	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	91.09	4.96	5.75	1.19	0.99	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	90.23	9.24	4.62	0.89	1.42	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	93.42	9.85	4.93	1.38	1.77	0.39	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	69.20	3.31	2.71	0.90	0.60	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	109.03	7.34	7.02	0.76	1.40	0.54	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	74.91	4.05	5.06	0.76	0.51	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	102.55	7.88	5.58	0.82	0.82	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	83.41	6.42	9.22	1.40	1.00	1.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	92.73	8.54	4.82	1.81	1.11	0.70	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	88.25	4.53	3.32	0.30	0.91	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	93.12	8.28	7.62	0.91	0.83	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	117.78	13.51	9.57	0.34	2.05	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	97.54	4.27	3.61	0.33	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	104.60	7.46	4.47	0.85	1.17	1.07	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	104.58	9.45	5.74	1.01	1.52	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	77.94	6.12	9.10	0.94	5.65	0.31	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	22.16	66.48	0.00	88.64	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	61.88	11.33	10.46	0.00	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	67.26	3.81	4.33	0.87	0.87	1.21	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	74.17	6.77	4.42	1.56	1.30	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	70.01	4.60	3.07	1.02	0.51	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	81.15	3.83	6.12	0.77	0.77	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	78.48	5.10	4.47	2.55	2.55	0.64	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	122.38	4.85	5.13	5.42	3.14	0.57	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	69.22	6.34	6.62	1.93	0.83	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	54.34	4.11	4.34	1.60	0.68	0.46	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	107.19	5.35	4.16	3.37	1.39	0.99	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	72.16	6.61	7.40	0.00	0.00	0.79	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	53.16	2.61	3.91	1.96	0.65	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	84.02	3.98	3.10	1.77	0.44	1.33	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	88.33	4.66	2.40	2.26	1.27	0.57	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	82.01	3.08	3.94	1.11	1.23	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	79.51	2.42	4.30	0.81	1.34	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	89.82	2.97	2.73	0.62	0.74	0.12	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	78.49	3.18	2.08	1.52	1.52	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	63.23	3.86	2.44	0.81	1.02	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	68.00	3.19	2.05	0.91	1.14	0.46	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	72.37	3.61	2.87	0.87	1.25	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	71.91	1.53	2.62	1.53	0.22	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	72.10	4.73	2.66	0.59	1.77	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	76.78	3.18	4.29	0.79	1.27	0.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	84.01	3.57	2.90	1.56	0.22	0.89	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	68.96	5.65	2.62	0.40	1.01	0.60	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	82.62	5.09	4.07	1.19	1.53	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	114.21	7.01	5.85	2.13	0.44	0.71	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	122.68	6.87	8.43	1.25	0.42	0.73	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	119.37	9.05	8.20	1.54	0.17	0.51	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	75.58	5.98	4.76	0.77	0.77	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	97.42	6.66	5.24	1.50	0.75	1.00	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	103.32	5.10	3.68	1.84	0.82	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	73.24	4.54	4.95	0.21	0.83	0.62	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	76.55	5.53	5.42	1.04	1.04	0.00	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	67.71	5.17	3.34	1.50	0.67	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	72.30	3.75	3.75	0.66	0.66	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	89.91	5.90	5.17	1.35	1.84	0.74	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	74.24	4.86	3.08	0.65	1.30	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	83.39	4.49	4.17	0.96	0.64	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	64.15	3.79	2.27	0.95	0.57	0.09	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	64.54	3.48	3.32	0.16	0.63	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	65.38	3.65	2.74	0.61	0.30	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	61.26	3.87	3.66	0.63	0.73	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	53.35	1.54	3.73	1.10	1.10	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	72.10	2.24	2.52	0.00	2.52	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	60.83	3.15	3.89	1.39	0.37	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	64.44	5.08	2.67	0.53	1.34	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	61.05	3.67	2.60	0.31	0.77	0.46	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	74.74	6.09	3.76	0.65	0.65	0.13	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	68.04	2.98	3.25	0.54	1.08	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	70.61	7.01	4.98	0.37	1.47	0.55	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	69.52	7.02	3.07	0.44	0.66	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	135.87	7.93	7.93	0.00	1.98	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	87.19	7.65	6.07	0.53	0.79	0.66	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	72.63	3.83	4.64	0.20	1.21	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	338.29	26.94	20.84	2.80	0.76	1.52	2.03
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	123.42	4.38	3.78	1.99	1.39	1.39	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	100.15	4.16	3.70	3.08	1.39	0.92	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	116.41	4.50	3.89	2.05	0.82	1.02	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	86.37	5.32	4.69	1.25	1.25	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	79.12	4.52	3.96	2.54	1.13	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	78.40	5.07	4.61	1.84	0.92	0.46	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	84.14	4.95	4.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	88.97	3.48	6.19	1.93	2.32	1.55	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	83.43	4.81	1.60	1.60	8.02	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	62.60	10.43	1.74	1.74	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	79.42	3.91	3.58	1.30	1.95	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	84.42	3.29	2.47	3.29	2.88	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	89.97	10.00	0.00	0.00	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	93.12	3.92	4.47	1.96	2.24	0.84	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	94.78	1.31	1.31	2.61	0.65	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	79.69	2.52	3.36	0.00	6.71	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	100.19	4.13	4.77	1.27	1.27	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	95.78	2.72	4.08	1.02	2.04	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	4.18	2.09	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	104.23	1.72	1.72	3.44	2.29	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	88.50	2.66	2.96	2.07	2.07	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	55.91	3.39	10.16	1.69	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	105.21	5.38	4.97	1.24	3.73	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	84.92	3.91	6.90	1.84	2.07	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	73.04	4.23	5.77	0.00	1.92	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	77.58	5.22	5.54	0.98	1.30	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	66.22	4.01	4.01	0.00	2.01	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	109.03	4.24	1.54	1.16	4.62	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	157.48	7.87	12.67	1.71	3.77	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	114.30	2.48	2.48	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	89.65	3.30	2.36	0.94	1.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	95.96	1.21	1.21	2.41	3.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	96.65	6.61	4.58	0.00	1.53	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	95.32	3.19	3.99	1.20	2.79	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	97.19	3.45	3.45	0.00	2.47	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	108.60	3.54	3.54	0.00	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	81.10	3.50	1.75	0.00	2.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	123.76	2.63	3.51	0.44	2.19	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	113.59	5.09	5.93	0.00	3.39	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	68.05	6.57	5.97	0.00	1.79	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	54.35	5.34	4.37	0.49	5.34	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	49.08	4.57	4.57	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	78.59	2.91	4.57	0.00	2.08	1.66	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	69.72	7.87	7.87	1.12	0.00	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	54.23	2.85	4.44	0.00	1.27	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	32.17	3.34	1.25	1.67	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	87.96	5.92	5.22	2.20	1.97	0.93	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	96.39	5.74	5.06	2.19	2.03	1.18	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	90.09	3.64	4.10	2.05	1.82	1.14	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	78.48	4.70	4.04	1.42	3.39	1.20	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	103.16	7.74	3.44	2.79	1.50	1.29	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	83.96	4.95	2.37	0.86	1.72	1.08	1.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	57.04	3.74	2.99	1.37	1.99	0.75	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	62.62	3.95	2.06	1.20	0.69	0.86	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	59.91	4.16	0.96	1.60	0.00	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	61.56	5.04	1.68	1.12	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	66.65	2.60	3.03	1.30	0.87	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	55.52	2.64	0.00	0.00	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	121.34	6.35	6.70	0.71	0.35	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	78.46	7.27	1.45	0.73	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	66.26	3.85	3.50	0.70	1.75	0.70	0.35
Hepatocyte, donor1	11523-119I2	83.53	13.32	6.05	1.21	3.63	0.00	0.00
Hepatocyte, donor2	11603-120I1	66.79	6.46	5.39	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	52.76	10.43	3.68	0.00	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	62.66	2.61	3.92	1.96	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	157.30	10.66	7.52	3.67	2.45	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	69.01	5.08	3.43	0.69	0.55	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	89.98	1.38	0.00	1.38	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	70.07	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	58.95	2.56	0.00	5.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	63.99	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	113.70	0.00	1.62	0.00	4.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	91.70	1.67	1.67	1.67	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	87.13	7.26	7.26	7.26	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	87.35	5.29	6.62	3.97	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	85.37	6.65	1.11	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	99.53	20.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	100.15	2.52	4.41	5.04	3.15	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	69.60	6.19	1.55	1.55	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	81.40	3.23	7.11	2.58	0.00	0.00	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	69.23	6.44	1.61	3.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	71.71	5.70	2.44	3.26	3.26	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	89.00	5.04	0.42	1.26	0.84	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	129.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	70.72	2.41	5.63	0.80	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	77.56	3.69	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	0.00	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	84.49	2.83	2.83	3.30	1.89	0.47	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	68.93	3.63	2.72	2.72	1.81	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	91.47	3.23	2.15	2.15	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	77.50	1.27	5.08	1.27	1.27	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	70.14	4.46	4.46	0.64	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	67.44	3.65	3.65	1.82	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	71.41	7.85	4.28	1.43	3.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	6.64	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	78.71	3.70	0.93	0.31	2.16	0.62	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	68.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	88.01	0.00	3.14	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	68.84	1.39	2.09	0.70	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	90.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	71.32	0.00	0.00	3.24	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	60.16	2.62	3.49	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	2.25	0.00	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	66.14	5.33	3.20	1.07	2.13	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	69.27	2.77	0.00	0.00	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	56.99	2.85	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	48.78	0.92	0.92	0.00	0.92	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	3.03	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	0.00	0.00	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	58.16	4.23	2.11	1.06	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	81.19	3.75	3.84	1.71	0.90	1.06	0.65
Keratinocyte - epidermal, donor2	11349-117G8	63.25	3.51	1.76	1.17	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	89.92	4.92	2.56	1.70	0.85	0.09	0.19
Keratinocyte - oral, donor1	11251-116E9	108.41	6.47	4.20	0.91	1.59	0.57	0.23
Keratocytes, donor1	11527-119I6	194.95	8.25	4.81	0.69	1.38	0.00	1.38
Keratocytes, donor2	11607-120I5	86.71	3.52	5.86	1.17	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	76.87	5.34	4.15	0.20	1.19	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	43.96	2.20	2.20	2.20	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	53.94	1.08	1.08	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	71.28	3.46	2.42	0.92	0.23	0.23	0.35
Lens Epithelial Cells, donor3	11690-122I7	96.47	6.96	5.75	2.22	0.61	0.71	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	62.02	3.20	2.49	0.47	0.83	0.95	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	36.28	2.79	0.84	0.84	0.28	0.28	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	51.79	3.15	2.05	0.63	1.10	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	38.72	1.61	1.61	0.54	1.08	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	42.86	2.52	2.52	0.00	1.26	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	44.20	2.16	2.05	0.32	0.86	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	43.91	2.46	2.05	0.00	1.23	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	33.12	2.53	2.53	0.25	1.01	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	42.08	3.66	2.25	0.70	1.69	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	44.70	1.19	2.37	1.58	0.00	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	41.30	3.10	1.55	0.58	0.78	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	34.07	2.41	2.96	0.56	0.56	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	43.20	2.44	1.05	0.00	1.05	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	41.26	3.34	3.10	0.72	0.72	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	39.01	3.16	1.79	0.55	0.96	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	44.96	0.92	1.85	0.62	0.92	1.23	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	34.29	2.49	2.18	0.62	0.31	1.25	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	45.93	3.11	2.74	0.55	0.55	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	36.86	2.63	2.30	0.66	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	37.49	2.34	1.76	0.29	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	37.59	2.49	3.98	0.25	0.50	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	38.31	1.94	4.36	0.00	1.94	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	41.20	2.42	2.15	0.54	0.27	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	45.26	2.27	1.67	0.61	0.45	0.76	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	40.95	2.59	0.00	1.04	1.04	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	43.76	2.93	3.56	0.42	0.42	0.63	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	36.99	3.61	2.41	0.90	0.45	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	43.34	3.44	2.06	0.69	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	38.57	3.95	1.51	0.19	1.13	1.13	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	40.61	2.33	1.80	1.06	0.85	0.53	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	47.97	1.94	1.94	0.97	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	49.29	1.32	1.65	1.32	0.99	0.33	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	39.52	2.35	1.73	0.50	1.12	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	40.35	2.22	2.22	0.37	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	36.32	2.22	0.74	0.00	0.00	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	44.14	2.61	2.06	1.10	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	44.39	2.25	1.29	0.32	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	41.08	3.65	3.04	0.61	0.91	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	40.87	3.50	1.68	0.70	0.56	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	43.38	2.84	0.71	0.36	1.07	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	43.15	1.94	0.97	0.48	0.48	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	39.21	3.27	2.02	0.47	0.62	0.78	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	48.34	2.86	3.58	0.72	0.00	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	39.20	0.98	1.63	0.98	0.33	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	31.08	1.65	2.83	0.71	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	68.93	6.06	3.96	0.87	0.37	1.24	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	40.21	1.54	2.56	1.02	0.00	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	40.28	2.69	2.69	0.60	1.49	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	65.71	6.80	0.00	2.27	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	56.00	6.14	1.53	1.53	5.37	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	66.80	4.45	3.71	2.23	0.74	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	58.39	7.62	3.81	1.69	3.39	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	61.19	2.11	2.11	2.11	2.11	0.70	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	52.30	3.74	5.60	1.87	1.87	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	48.95	4.12	3.61	1.03	3.61	2.58	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	54.72	4.76	1.19	0.00	1.19	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	50.21	9.73	2.71	3.39	1.81	1.81	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	53.80	3.49	2.91	0.87	4.94	0.87	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	59.42	5.85	4.05	1.80	2.70	1.80	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	66.25	5.96	3.93	4.34	0.54	0.95	1.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	55.97	2.57	2.05	2.57	4.11	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	63.87	2.47	2.12	2.82	3.53	0.35	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	61.97	2.00	2.00	5.33	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	62.65	7.13	2.55	3.06	6.11	1.53	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	76.04	5.07	2.93	4.27	2.13	2.67	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	60.08	5.48	2.83	2.46	2.27	1.13	1.70
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	45.40	3.68	2.45	2.45	3.07	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	77.47	4.08	1.63	4.89	1.63	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	66.85	4.37	2.92	3.96	4.16	2.29	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	66.70	3.92	6.17	3.08	6.45	0.84	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	53.58	9.27	6.18	2.06	1.03	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	63.29	6.97	5.81	2.90	3.77	0.87	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	58.29	5.08	3.89	1.20	2.99	1.49	2.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	57.54	2.21	3.32	1.66	2.21	1.66	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	63.98	7.07	4.60	1.77	5.30	2.12	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	62.69	5.53	3.69	1.48	3.32	1.84	2.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	50.66	9.21	5.76	3.45	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	62.94	6.91	3.84	2.69	5.37	0.77	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	55.48	4.53	2.83	1.70	7.93	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	72.20	5.74	4.10	4.92	1.64	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	61.00	4.07	3.62	4.07	4.07	1.36	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	56.73	2.15	2.87	2.87	4.31	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	76.93	9.71	3.73	5.23	2.24	2.24	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	67.63	6.32	4.09	4.09	4.46	1.11	3.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	62.89	5.17	3.02	4.31	2.15	1.72	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	66.79	4.28	4.28	1.71	1.71	2.57	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	66.97	5.66	5.00	2.33	3.66	1.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	63.35	1.81	3.62	2.41	3.62	1.21	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	51.90	3.55	2.84	2.84	1.42	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	62.90	4.81	2.41	3.09	2.06	1.37	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	50.45	4.29	2.15	2.68	3.76	0.54	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	52.52	4.04	4.04	2.02	0.67	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	57.78	7.78	5.19	3.33	4.44	0.74	3.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	62.80	5.81	2.33	1.16	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	51.83	4.23	1.06	3.17	4.23	1.06	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	64.82	7.20	2.80	2.40	2.40	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	63.24	2.91	1.45	1.45	0.73	3.63	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	57.49	7.67	3.07	3.83	0.77	2.30	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	60.18	4.93	8.39	4.93	4.44	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	44.22	3.76	3.76	1.88	1.88	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	71.90	4.53	5.53	2.01	1.51	2.01	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	61.74	4.96	3.15	3.60	3.15	1.80	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	58.52	0.00	3.44	6.88	1.72	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	77.94	3.56	2.67	1.34	4.90	0.00	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	68.82	5.47	3.52	2.74	3.13	1.17	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	60.70	4.62	1.32	1.98	1.98	3.30	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	74.73	4.15	3.63	3.63	1.56	1.56	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	76.57	8.31	4.81	3.94	8.31	0.44	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	59.82	3.35	3.35	2.80	2.80	2.80	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	69.78	6.18	2.65	3.97	1.32	3.53	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	68.27	3.86	7.33	3.47	3.86	0.00	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	60.26	5.06	3.54	1.52	3.04	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	65.36	4.33	2.40	2.40	2.40	2.40	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	54.86	3.58	2.78	1.99	5.57	0.80	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	54.69	4.25	3.04	1.22	4.86	1.82	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	56.03	4.15	0.00	1.38	2.08	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	73.72	4.56	4.94	3.80	6.08	1.90	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	68.17	5.68	3.61	3.10	5.68	2.58	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	70.14	1.21	3.02	3.02	2.42	1.21	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	65.60	3.80	3.49	3.49	6.97	1.58	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	79.96	4.80	4.26	5.33	3.20	2.67	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	58.62	3.45	2.87	2.87	2.87	1.15	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	58.11	6.17	3.09	3.60	5.14	1.54	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	74.27	3.54	3.54	4.95	3.54	2.12	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	54.48	3.40	2.27	2.84	4.54	1.13	4.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	72.80	2.50	4.99	3.33	4.58	2.08	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	70.47	5.48	4.70	2.35	4.70	5.48	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	53.86	1.25	2.51	4.18	1.67	3.76	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	75.74	7.43	1.86	2.32	2.79	1.39	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	68.91	4.68	1.34	3.35	1.34	0.67	3.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	73.25	1.60	3.21	5.88	1.07	2.67	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	84.86	4.04	3.23	2.42	4.45	0.81	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	74.34	7.34	2.75	1.84	2.75	1.84	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	68.46	4.45	3.56	4.45	1.78	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	66.10	6.27	1.14	3.42	0.00	1.71	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	60.59	3.07	4.60	3.07	0.77	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	70.04	2.74	1.09	4.38	1.64	1.09	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	79.29	4.01	1.34	3.56	2.23	1.78	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	83.97	6.24	3.90	4.68	1.30	2.08	2.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	64.32	2.65	2.65	1.33	2.65	0.66	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	66.52	8.31	0.00	0.00	2.08	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	35.33	7.29	3.42	0.46	0.46	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	50.46	9.73	4.22	1.10	0.55	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	44.04	7.47	1.97	0.13	0.13	0.66	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	48.85	5.31	2.66	0.53	1.06	1.59	1.06
Mallassez-derived cells, donor2	11929-125I3	105.53	9.51	6.18	1.90	0.48	0.79	0.63
Mallassez-derived cells, donor3	11930-125I4	92.70	6.25	5.70	0.97	1.11	0.83	0.14
Mammary Epithelial Cell, donor1	11273-116H4	107.42	5.48	3.29	2.29	1.30	0.80	0.40
Mammary Epithelial Cell, donor2	11350-117G9	83.39	3.19	2.61	0.87	1.74	0.87	0.58
Mammary Epithelial Cell, donor3	11422-118F9	46.14	2.99	2.24	0.75	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	894.20	282.02	208.13	48.13	4.75	56.95	33.22
Mast cell, donor1	11563-120D6	74.51	7.25	5.30	1.73	0.54	0.87	0.54
Mast cell, donor2	11565-120D8	72.51	12.78	4.46	0.59	0.30	0.30	0.89
Mast cell, donor3	11566-120D9	92.53	19.59	6.75	1.58	1.35	1.13	1.35
Mast cell, donor4	11567-120E1	64.00	15.96	8.16	0.89	0.00	0.89	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	93.15	17.85	7.21	1.33	0.33	0.44	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	91.05	37.36	28.02	4.67	2.33	0.58	1.75
Mast cell, expanded, donor5	11939-126A4	57.82	6.42	1.95	0.69	0.57	0.80	0.00
Mast cell, expanded, donor8	11941-126A6	45.86	7.70	5.02	1.84	0.50	0.33	0.17
Melanocyte - dark, donor1	11502-119F8	70.05	4.68	2.39	0.90	0.80	0.60	0.30
Melanocyte - dark, donor2	11582-120F7	50.87	2.42	5.19	0.35	2.08	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	70.48	4.35	2.97	0.80	0.43	0.58	0.43
Melanocyte - light, donor1	11274-116H5	55.48	1.88	1.65	0.24	0.71	0.24	0.00
Melanocyte - light, donor2	11351-117H1	39.58	0.00	0.00	0.00	2.05	0.68	0.00
Melanocyte - light, donor3	11423-118G1	39.03	2.60	2.60	0.87	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	68.62	3.75	1.77	1.35	1.25	0.21	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	52.71	2.15	2.42	1.34	1.34	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	61.61	5.36	3.21	1.34	1.34	0.00	0.00
Meningeal Cells, donor1	11493-119E8	186.09	9.55	5.83	1.36	0.62	0.87	0.87
Meningeal Cells, donor2	11573-120E7	108.72	4.84	7.92	1.76	0.00	0.88	0.44
Meningeal Cells, donor3	11654-122E7	115.08	6.52	4.24	1.47	1.14	0.73	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	77.56	3.71	3.99	0.86	0.86	0.86	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	85.24	6.84	7.75	1.51	0.50	0.40	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	30.23	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	82.41	2.62	3.92	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	60.28	1.44	5.02	0.72	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	85.34	5.72	4.24	1.91	1.06	1.06	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	78.92	5.03	4.02	1.51	1.01	1.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	99.77	3.74	1.98	1.76	0.88	0.88	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	70.87	1.46	3.65	0.00	0.73	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	74.68	2.05	2.46	1.43	0.82	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	73.27	3.60	3.05	1.25	0.97	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	49.81	5.20	1.49	0.00	0.37	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	88.94	6.71	5.39	0.53	1.32	0.00	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	61.13	6.23	12.17	0.59	1.19	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	44.38	4.67	2.34	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	78.13	7.04	3.20	0.00	0.64	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	84.00	6.03	3.19	0.71	0.71	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	75.37	6.57	3.13	0.31	1.25	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	67.49	2.90	2.90	0.00	0.00	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	58.87	4.24	2.92	1.59	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	63.06	6.51	2.50	1.00	0.00	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	63.01	3.32	2.75	0.79	0.36	0.79	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	22.96	0.00	1.35	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	42.85	3.94	3.45	0.99	0.49	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.34	7.66	3.24	0.59	0.88	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	39.36	4.65	2.79	0.62	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	31.74	6.22	2.70	0.62	0.62	0.41	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	6.95	6.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	38.04	5.51	3.50	0.00	0.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	34.45	3.26	4.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	32.31	4.47	3.45	0.61	0.61	0.20	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	30.09	5.15	1.98	1.19	0.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	26.55	4.42	2.65	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	33.43	4.94	4.56	0.00	1.14	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	1.32	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	27.59	4.03	2.97	0.21	0.21	0.21	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	17.50	3.68	0.00	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	28.91	2.98	1.19	0.60	0.30	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	17.56	4.52	2.76	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	27.57	5.23	2.14	0.48	1.43	0.00	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.16	2.76	2.76	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	28.78	2.53	2.76	0.23	0.23	0.46	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	31.13	4.00	5.47	0.42	0.42	0.63	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	27.11	4.08	3.06	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	34.76	3.65	2.57	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.23	3.56	2.89	0.22	0.44	0.00	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	24.31	4.16	2.85	0.44	0.22	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	20.28	2.53	0.51	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	3.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	25.00	5.44	2.45	0.27	0.82	0.54	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	24.11	6.47	3.23	0.59	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	13.08	2.18	2.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	27.39	4.81	2.40	0.96	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	26.42	3.60	2.80	0.80	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	19.20	4.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	38.54	1.50	2.00	1.00	1.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	36.79	4.38	3.50	1.31	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	25.38	4.41	0.00	0.00	0.00	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.65	3.20	1.28	1.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	35.20	4.96	2.98	0.25	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	22.96	2.78	3.48	0.70	0.00	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	2.21	4.42	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	37.61	3.42	3.42	0.34	0.34	0.34	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	28.88	2.63	4.81	0.44	0.00	1.31	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.43	1.78	3.20	0.71	0.00	0.71	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	38.44	2.81	4.49	0.56	0.00	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	31.17	2.91	4.16	0.83	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.15	1.17	1.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	30.47	6.33	3.02	0.30	0.60	0.90	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	41.74	4.17	1.67	0.42	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	26.78	0.92	1.85	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	26.18	2.28	3.98	0.57	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	27.08	3.73	3.18	0.00	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	35.50	3.37	2.07	1.30	1.04	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	32.60	2.57	3.43	1.29	0.86	1.29	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	18.42	0.00	1.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	29.09	0.53	1.87	0.53	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	46.99	5.09	2.99	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	25.14	1.98	1.84	0.85	0.28	0.42	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	34.40	2.55	3.50	0.96	0.64	1.27	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	46.66	3.10	2.87	0.66	0.00	1.55	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	21.61	2.28	1.52	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	41.20	2.56	1.14	0.85	0.28	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	39.57	4.18	3.69	0.98	0.74	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	19.55	3.91	1.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	34.40	3.53	2.65	0.29	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	45.84	3.75	3.17	0.29	0.86	1.15	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	37.51	6.18	3.71	0.82	0.41	1.24	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	36.63	2.68	3.87	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	0.00	7.53	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	46.34	1.78	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	51.59	4.93	5.91	0.66	0.33	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	43.13	5.26	1.05	0.00	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	32.42	6.52	4.35	0.59	0.59	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.05	2.79	4.66	0.93	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	37.93	6.01	5.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	33.03	4.00	2.66	0.27	0.53	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	37.55	5.77	3.17	0.23	0.57	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.79	4.42	1.47	1.47	0.74	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	42.14	5.50	3.66	0.73	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	6.22	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	37.95	8.02	3.21	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	50.23	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	33.33	4.04	8.08	0.00	2.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	30.78	3.79	3.37	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	20.43	8.17	4.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	13.35	1.27	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	10.53	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	4.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	35.89	6.52	3.26	3.26	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	4.75	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	95.65	4.74	3.66	0.65	1.94	0.43	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	77.87	3.66	5.23	1.57	0.52	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	48.06	0.67	2.67	1.33	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	39.23	1.67	2.09	0.83	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	52.86	4.56	5.13	0.19	0.76	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	75.01	0.00	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	37.40	1.36	2.04	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	91.88	1.84	7.35	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	30.55	2.09	2.93	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	54.39	2.32	2.79	0.46	0.70	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	37.56	4.59	3.78	0.27	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	54.45	3.78	3.36	0.84	0.42	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	33.40	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	41.69	3.47	6.45	0.00	0.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	47.10	1.08	3.79	0.27	1.08	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	41.26	2.95	3.63	1.59	1.13	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	35.11	3.10	2.12	0.65	0.49	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	47.75	3.46	4.19	0.00	1.09	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	35.01	2.65	4.24	0.00	1.59	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	28.81	1.80	1.80	1.20	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	44.63	3.61	5.58	0.33	2.63	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	39.68	2.76	3.09	0.98	0.33	0.16	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	47.09	4.76	3.17	0.53	0.71	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	28.13	1.41	2.81	0.70	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	36.32	2.76	5.06	0.00	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	45.95	6.11	5.14	0.00	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	63.80	3.10	7.24	1.03	3.45	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	161.82	10.11	12.64	0.00	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	45.67	3.56	3.12	0.22	0.45	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	41.49	2.96	2.96	1.69	1.69	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	42.96	2.14	2.85	0.47	0.47	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	45.93	8.58	2.15	0.86	1.29	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	261.81	27.08	18.06	0.00	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	40.32	2.67	3.00	0.33	0.33	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	59.51	2.71	3.16	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	40.08	3.57	3.17	0.40	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	45.50	5.57	2.79	0.00	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	60.54	6.43	3.41	0.38	2.27	0.38	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	44.65	7.17	3.26	1.96	0.98	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	32.25	3.05	2.18	0.00	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	59.70	4.98	4.98	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	43.21	3.53	5.29	0.88	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	40.56	3.99	2.66	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	48.61	5.46	1.98	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	43.64	4.21	7.27	0.38	0.38	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	81.36	7.56	3.33	1.21	0.60	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	74.49	6.85	3.32	0.66	0.66	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	44.05	4.07	1.36	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	137.96	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	45.12	4.88	3.05	0.61	1.83	0.61	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	48.78	4.09	3.78	1.89	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	41.46	2.72	2.72	0.91	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	53.01	3.96	7.12	0.00	2.37	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	49.88	5.67	11.34	0.00	6.80	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	85.98	15.17	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	79.13	6.71	5.22	1.74	1.61	0.99	0.62
Myoblast, donor2	11322-117D8	66.55	4.79	4.03	0.96	1.53	0.19	0.38
Myoblast, donor3	11398-118D3	71.30	5.38	4.88	1.01	0.50	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	73.55	3.36	4.09	1.17	0.29	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	91.64	7.07	5.54	1.85	0.62	0.92	0.31
Natural Killer Cells, donor2	11311-117C6	77.20	6.03	4.22	1.51	1.81	1.21	1.51
Natural Killer Cells, donor3	11387-118C1	82.27	6.63	6.07	0.74	1.10	0.92	0.55
Neural stem cells, donor1	11275-116H6	98.36	10.16	8.35	2.90	0.00	0.73	0.00
Neural stem cells, donor2	11352-117H2	163.68	11.55	9.63	5.78	0.00	5.78	7.70
Neurons, donor1	11494-119E9	69.41	5.69	4.55	3.41	0.00	0.00	0.00
Neurons, donor2	11574-120E8	67.37	3.96	0.88	0.44	0.44	0.66	0.66
Neurons, donor3	11655-122E8	69.06	3.29	0.82	1.64	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	6.50	3.71	2.78	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	5.80	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	13.44	0.00	3.67	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	99.03	7.12	6.41	1.90	1.54	0.71	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	45.91	3.58	2.28	1.30	0.65	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	54.15	2.61	2.01	0.60	0.60	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	77.91	6.33	7.43	0.96	0.69	0.28	0.41
Olfactory epithelial cells, donor2	11934-125I8	83.23	6.51	5.36	0.58	6.22	1.30	0.58
Olfactory epithelial cells, donor3	11935-125I9	73.55	4.65	5.90	1.02	1.70	0.11	0.23
Olfactory epithelial cells, donor4	11936-126A1	93.89	6.82	4.38	0.68	0.58	0.49	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	104.72	6.02	3.61	1.81	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	77.63	6.17	5.96	0.43	0.21	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	32.01	0.00	2.29	1.14	2.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	46.55	4.34	3.72	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	78.57	5.86	6.06	1.37	0.98	0.00	0.20
Osteoblast, donor2	11354-117H4	130.63	7.73	9.13	1.40	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	84.24	8.18	6.40	1.07	1.07	0.53	0.36
Pancreatic stromal cells, donor1	11249-116E7	80.44	5.56	5.81	1.10	1.26	0.08	0.51
Pericytes, donor1	11491-119E6	54.52	3.78	2.67	1.00	0.00	0.33	0.22
Pericytes, donor2	11571-120E5	53.20	3.85	2.72	0.68	0.23	0.68	0.23
Pericytes, donor3	11652-122E5	86.06	7.93	2.85	0.81	1.02	0.61	0.00
Perineurial Cells, donor1	11499-119F5	97.20	4.29	3.16	0.23	0.68	0.11	0.11
Perineurial Cells, donor2	11579-120F4	76.37	5.61	3.86	1.01	0.74	0.37	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	69.80	10.84	7.65	1.59	0.00	0.00	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	35.02	4.65	3.18	0.73	1.47	0.24	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	60.57	5.95	3.36	0.65	0.39	0.26	0.13
Placental Epithelial Cells, donor1	11278-116H9	64.57	3.83	1.20	0.96	0.24	0.48	0.48
Placental Epithelial Cells, donor2	11355-117H5	74.30	5.54	2.22	1.11	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	58.90	2.75	1.37	0.59	0.59	0.79	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	72.47	10.76	4.11	0.32	6.33	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	96.80	9.75	6.19	1.69	1.31	0.56	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	69.44	6.40	5.48	0.65	0.39	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	97.26	9.91	6.75	0.45	2.70	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	101.98	9.91	6.93	0.96	0.43	0.43	0.21
Preadipocyte - omental, donor2	11329-117E6	110.86	9.17	8.73	1.75	1.31	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	106.15	9.02	8.17	0.86	2.29	0.29	0.14
Preadipocyte - perirenal, donor1	11469-119C2	64.96	5.91	0.98	0.00	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	63.88	10.44	5.22	0.31	0.31	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	102.53	7.79	7.08	2.12	2.66	0.71	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	90.76	9.03	8.34	1.19	1.19	0.34	0.51
Preadipocyte - visceral, donor1	11280-116I2	103.49	9.41	8.38	1.58	0.84	0.84	0.47
Preadipocyte - visceral, donor2	11357-117H7	73.17	5.98	4.14	0.00	2.30	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	66.35	7.42	4.49	0.21	1.67	0.21	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	143.61	10.71	7.09	2.87	1.96	0.60	0.60
Prostate Epithelial Cells, donor2	11331-117E8	61.48	4.47	2.03	1.35	1.35	1.22	0.95
Prostate Epithelial Cells, donor3	11404-118D9	77.77	4.96	2.82	0.73	0.61	0.43	0.37
Prostate Stromal Cells, donor1	11254-116F3	94.65	8.77	7.86	1.03	1.48	0.80	0.00
Prostate Stromal Cells, donor2	11332-117E9	98.08	6.10	5.56	0.72	1.08	0.54	0.36
Prostate Stromal Cells, donor3	11405-118E1	81.65	5.84	9.38	0.63	2.29	0.94	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	77.74	4.74	5.11	1.09	0.00	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	69.80	2.08	1.66	1.73	0.90	1.18	0.55
Renal Epithelial Cells, donor1	11517-119H5	64.93	3.04	0.51	1.01	0.51	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	60.46	1.42	3.56	1.42	1.42	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	83.84	2.96	2.22	1.69	1.27	0.21	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	53.11	3.40	1.36	0.00	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	74.39	2.02	2.02	0.94	0.81	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	70.82	2.22	3.11	1.11	1.55	0.67	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	45.92	4.66	3.33	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	94.20	4.18	2.20	1.32	0.22	0.88	0.22
Renal Mesangial Cells, donor2	11598-120H5	79.00	5.02	3.76	1.88	0.00	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	41.06	1.66	1.66	0.55	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	111.93	4.29	2.95	0.81	1.07	1.88	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	61.99	1.69	5.06	1.69	0.84	0.42	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	70.39	3.28	0.77	0.96	0.96	0.77	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	65.34	4.67	3.89	0.52	1.04	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	79.30	5.40	7.39	1.14	0.28	0.85	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	48.37	2.06	4.12	0.00	1.03	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	51.69	3.51	6.27	0.25	1.76	0.50	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	70.96	9.35	6.01	1.07	0.40	0.67	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	43.78	1.79	3.57	0.89	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	39.08	3.85	6.05	0.55	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	51.62	5.22	2.90	0.58	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	67.22	3.77	2.60	1.82	0.52	0.65	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	55.81	4.17	2.68	0.99	0.70	0.10	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	64.92	5.47	3.57	1.12	0.45	0.22	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	72.57	5.46	2.73	1.74	1.12	0.50	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	67.36	2.91	3.73	1.28	0.93	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	62.41	3.24	2.77	1.16	2.08	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	56.41	2.88	1.64	0.55	0.82	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	53.40	4.99	1.36	0.15	1.06	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	49.46	3.94	1.61	1.61	0.90	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	62.55	2.58	1.15	0.86	0.43	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	57.84	3.33	3.00	0.64	0.75	0.43	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	57.75	5.09	3.54	0.44	0.89	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	58.31	2.68	1.72	0.96	0.76	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	56.18	4.66	3.07	1.40	0.37	0.93	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	76.29	5.64	4.32	0.38	0.94	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	57.99	3.98	2.79	0.66	0.53	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	64.44	4.96	4.28	1.36	1.17	0.29	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	64.16	6.30	4.77	0.57	0.57	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	55.53	2.67	2.14	1.07	0.32	0.43	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	57.46	4.20	2.24	0.84	1.96	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	66.65	3.76	2.91	0.68	0.85	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	55.43	3.65	1.64	0.36	0.18	0.55	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	68.55	5.52	2.94	1.10	0.49	0.37	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	65.55	5.10	4.16	0.94	0.81	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	78.07	3.30	1.18	0.47	0.94	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	68.85	4.37	2.98	1.19	1.79	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	60.80	3.98	2.57	1.64	1.17	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	67.60	4.35	1.87	1.45	0.41	0.62	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	59.73	3.76	2.43	1.33	2.88	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	67.05	4.80	3.55	1.46	0.00	0.63	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	66.89	2.29	2.69	0.81	0.40	0.81	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	58.75	4.26	1.87	0.85	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	63.04	6.56	4.05	0.77	0.39	0.39	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	64.13	2.75	1.03	1.20	0.34	0.34	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	48.42	4.66	2.06	1.37	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	52.04	3.61	2.46	1.31	1.64	0.33	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	49.60	2.05	1.53	1.36	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	64.51	4.59	3.85	1.48	0.30	0.30	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	53.58	2.67	2.93	0.80	0.00	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	51.99	2.49	1.38	0.55	0.83	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	50.24	3.57	4.05	1.19	0.71	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	63.69	6.25	3.22	0.40	0.40	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	52.55	4.33	3.20	0.75	0.47	0.09	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	56.60	5.94	1.75	0.35	1.05	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	56.21	2.12	3.02	0.30	0.60	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	49.81	2.20	3.79	0.61	0.61	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	66.37	7.28	5.82	1.02	0.15	0.44	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	55.37	2.43	6.69	0.00	1.83	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	45.81	3.32	2.71	0.60	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	51.57	4.75	2.49	0.68	1.36	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	61.41	2.70	3.59	0.90	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	57.62	4.01	2.83	0.59	0.47	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	50.80	4.70	4.91	0.85	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	52.89	4.81	3.00	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	51.53	2.63	1.50	0.56	0.56	0.38	0.56
Schwann Cells, donor2	11578-120F3	71.45	0.00	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	61.34	2.19	1.53	0.88	2.19	0.22	0.00
Sebocyte, donor1	11220-116B5	228.42	14.79	3.83	3.29	0.00	2.74	1.10
Sebocyte, donor2	11301-117B5	99.26	7.81	4.60	2.30	1.84	0.92	1.38
Sebocyte, donor3	11378-118B1	105.12	4.12	2.27	1.44	0.21	1.65	0.41
Sertoli Cells, donor1	11255-116F4	87.80	8.28	6.63	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	67.78	14.12	5.65	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	73.02	4.66	4.13	0.62	0.97	0.35	0.26
Skeletal Muscle Cells, donor2	11358-117H8	36.87	6.51	4.34	0.72	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	66.88	3.34	3.34	0.84	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	66.61	4.71	2.36	1.26	0.79	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	69.86	4.31	2.82	0.15	1.49	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	88.34	3.23	2.00	0.77	0.77	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	84.30	5.04	3.40	1.01	1.39	0.38	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	75.91	3.71	4.14	0.57	1.28	0.29	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	91.17	5.75	3.17	0.79	1.29	0.30	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	92.00	8.93	8.17	1.10	0.67	0.25	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	52.11	5.07	1.45	0.72	0.72	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	51.60	5.23	4.40	0.28	0.55	0.41	0.14
Skin - palm, donor1	10286-104F7	45.66	8.06	5.37	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	43.68	2.02	1.15	1.01	0.72	1.15	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	79.34	3.27	0.00	3.27	0.82	3.27	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	49.72	2.34	2.34	0.13	1.43	0.52	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	81.46	5.28	4.03	2.50	1.81	0.97	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	59.78	2.95	1.41	1.41	1.83	0.56	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	86.06	7.82	2.33	1.90	0.63	1.69	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	81.55	4.72	2.85	1.12	1.57	0.45	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	98.44	4.01	1.85	0.00	4.94	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	109.83	7.56	5.34	0.89	2.00	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	101.69	5.29	4.11	1.18	0.59	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	88.40	4.42	5.97	0.88	0.88	1.33	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	105.53	5.91	5.12	0.39	0.79	2.36	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	87.30	4.64	1.55	0.77	0.77	2.32	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	48.04	7.01	4.00	2.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	91.69	5.72	2.66	0.67	0.53	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	94.65	5.54	6.43	0.22	1.77	1.11	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	80.53	4.74	3.58	1.02	0.64	1.02	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	63.82	3.91	2.28	0.98	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	83.58	5.91	3.54	0.30	0.30	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	64.21	3.99	3.56	1.00	0.14	0.57	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	70.11	4.39	1.30	2.28	0.65	0.65	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	41.71	3.35	0.91	0.91	0.00	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	81.58	5.56	3.79	1.26	0.51	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	110.17	6.12	0.00	0.00	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	49.11	2.86	2.38	0.48	1.91	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	69.90	3.83	2.51	0.88	1.62	0.00	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	77.06	4.30	4.09	1.08	3.01	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	74.94	3.67	3.15	0.94	0.84	0.21	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	118.48	8.35	6.19	1.55	0.46	1.24	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	75.45	6.47	2.16	1.08	1.08	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	66.64	5.08	2.39	0.90	0.00	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	75.79	3.41	3.76	1.37	1.37	1.02	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	72.80	4.95	4.71	0.71	0.94	0.16	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	128.12	7.15	6.64	1.81	0.70	2.11	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	94.43	4.55	7.28	1.14	1.82	0.68	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	86.35	5.43	5.43	0.60	1.81	0.00	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	110.21	4.24	3.71	2.12	1.85	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	94.01	5.73	3.86	1.60	0.93	0.53	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	83.77	6.89	10.39	1.50	1.25	0.88	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	60.88	6.85	3.80	1.01	2.54	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	101.02	8.74	7.24	1.06	1.06	0.60	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	60.76	4.50	2.25	1.50	0.00	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	184.79	2.58	15.51	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	96.27	11.16	8.37	0.93	0.47	0.93	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	93.91	2.02	4.54	1.51	1.51	2.02	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	89.00	8.15	4.07	1.25	0.94	1.57	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	52.80	2.65	0.88	1.47	0.88	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	94.05	4.08	3.33	1.08	0.58	0.33	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	63.07	1.87	0.47	0.93	0.47	0.93	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	97.58	8.35	6.48	1.30	0.29	0.72	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	80.57	6.88	4.59	1.53	2.55	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	63.56	7.33	3.57	1.32	1.13	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	93.35	6.29	4.61	0.98	1.26	0.00	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	77.09	7.54	6.20	1.09	0.59	0.92	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	46.67	2.38	1.43	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	91.99	4.40	7.58	0.49	0.24	0.73	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	109.37	9.50	5.74	1.99	2.43	1.33	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	62.03	2.93	3.22	0.29	1.46	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	62.00	3.69	3.89	0.78	0.97	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	58.44	2.38	3.70	0.79	2.38	0.26	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	50.21	2.98	5.95	0.00	3.72	0.00	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	83.73	3.95	7.19	1.08	2.52	1.44	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	64.45	2.84	3.41	1.70	1.42	0.00	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	64.20	1.58	3.15	0.39	0.39	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	60.44	4.57	3.56	0.25	3.56	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	56.30	2.00	3.19	0.40	1.60	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	51.00	0.42	3.76	0.00	2.93	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	49.96	2.75	3.21	1.83	1.83	0.00	0.46
Synoviocyte, donor1	11291-117A4	115.97	10.44	11.11	1.01	1.85	0.34	0.84
Synoviocyte, donor2	11368-117I9	63.19	7.88	5.53	0.67	1.34	0.17	0.00
Synoviocyte, donor3	11440-118H9	53.39	3.57	4.24	0.45	0.89	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	115.42	7.15	5.00	2.14	0.71	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	49.55	1.98	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	53.49	3.01	5.33	0.46	0.46	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	83.23	3.94	2.37	1.08	0.79	0.50	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	44.07	2.32	1.55	0.77	0.39	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	41.80	2.86	3.44	0.00	0.57	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	76.77	11.32	5.54	1.35	0.62	0.74	0.25
Urethra, donor2	10319-105A4	35.97	7.19	1.80	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	74.39	2.13	1.33	0.27	0.53	0.27	1.06
Urothelial Cells, donor2	11600-120H7	64.49	3.61	0.00	1.20	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	47.45	2.52	1.60	0.00	0.46	0.23	0.00
Urothelial cells, donor0	11216-116B1	122.37	5.13	2.01	1.11	0.89	0.89	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	66.73	7.12	3.56	0.00	0.89	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	37.17	4.29	2.86	0.00	4.29	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.86	2.05	2.74	0.68	0.68	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	40.63	4.48	1.72	0.69	0.69	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	42.42	2.91	2.32	0.00	0.00	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	51.02	4.16	1.04	0.00	0.00	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	51.40	4.59	2.75	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	32.86	1.83	4.56	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	64.52	6.54	5.30	1.85	0.62	0.74	0.74
Wilms' tumor cell line:HFWT	10597-108E3	37.84	1.76	0.88	0.88	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	72.34	5.03	2.51	0.28	0.28	0.28	0.28
achilles tendon, donor2	10292-104G4	33.06	8.27	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	94.59	11.47	8.67	1.02	0.76	0.51	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	92.64	12.07	7.66	1.86	0.70	0.23	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	103.99	5.34	3.56	1.54	0.95	0.95	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	124.08	11.43	4.63	2.18	1.63	1.63	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	112.71	7.87	3.65	1.97	1.12	0.84	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	58.37	7.61	4.02	2.54	0.00	0.85	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	84.66	13.34	5.72	1.09	0.82	0.27	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	107.08	7.49	2.64	3.08	0.44	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	82.08	4.49	3.68	2.86	1.23	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	87.76	8.93	9.32	2.72	0.39	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	87.40	5.70	4.23	1.29	1.47	0.00	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	81.91	7.80	3.90	3.90	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	98.99	8.13	4.65	1.86	0.46	0.46	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	97.35	2.85	2.07	1.81	1.04	0.26	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	76.28	5.55	3.51	0.58	0.58	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	51.59	3.72	2.79	1.86	0.46	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	70.32	4.11	4.94	1.23	0.82	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	45.74	4.91	2.15	0.61	0.31	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	79.37	10.24	4.69	0.85	0.85	0.85	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	69.15	9.71	3.64	2.43	0.00	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	85.21	7.70	4.57	2.65	0.96	0.24	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	93.10	6.90	5.12	2.00	0.45	1.11	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	72.38	3.34	2.33	1.67	0.00	0.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	61.32	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	82.49	3.77	7.91	0.75	0.75	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	102.93	9.16	8.29	2.18	1.31	2.62	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	63.73	5.62	7.50	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	81.01	9.42	5.89	1.88	1.41	0.71	0.71
adipose tissue, adult, pool1	10010-101C1	53.05	5.43	3.10	0.62	0.31	0.47	0.31
adipose, donor1	10184-103D4	84.44	8.80	18.18	0.59	5.28	1.17	0.59
adipose, donor2	10185-103D5	33.66	4.06	2.84	0.81	0.41	0.00	0.81
adipose, donor3	10186-103D6	52.28	4.08	3.81	1.09	0.82	0.54	1.09
adipose, donor4	10187-103D7	86.68	4.33	7.80	0.87	1.73	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	68.81	3.63	2.37	3.79	0.63	2.05	0.79
adrenal gland, adult, pool1	10081-102A9	58.20	3.64	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	87.11	6.94	3.87	2.53	1.47	1.33	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	53.24	1.43	1.07	1.07	1.07	1.43	0.00
amniotic membrane cells, donor1	12235-129G3	91.81	9.97	4.87	1.39	1.62	0.70	0.93
amniotic membrane cells, donor2	12236-129G4	92.64	4.40	4.06	1.01	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	63.63	7.66	3.24	1.77	0.29	0.59	0.59
amygdala - adult, donor10196	10167-103B5	66.40	8.30	0.00	2.37	0.00	2.37	1.19
amygdala, adult, donor10252	10151-102I7	64.89	5.07	2.23	2.23	0.41	0.81	0.81
amygdala, newborn, donor10223	10360-105E9	38.41	2.58	2.26	1.61	0.97	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	155.60	7.64	4.33	0.76	0.64	1.02	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	92.00	3.97	2.87	3.09	0.88	1.76	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	68.14	5.01	4.68	1.34	0.33	0.67	0.33
aorta, adult, pool1	10052-101G7	74.14	10.00	5.10	1.37	0.78	0.20	0.78
appendix, adult	10189-103D9	59.38	4.66	5.43	0.00	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	70.85	5.85	6.19	0.69	0.34	1.38	0.69
artery, adult	10190-103E1	38.04	4.08	1.36	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	79.53	3.48	2.32	0.72	0.58	0.00	0.29
b cell line:RPMI1788	10427-106D4	142.90	12.64	11.00	0.74	0.89	1.64	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	95.44	12.49	6.66	1.11	1.66	1.11	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	91.49	5.06	3.57	1.29	0.50	0.99	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	122.19	6.86	4.02	2.01	2.01	0.33	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	38.59	6.15	7.27	0.00	1.12	0.00	0.00
bladder, adult, pool1	10011-101C2	63.01	8.47	3.91	0.76	0.87	0.22	1.09
blood, adult, pool1	10053-101G8	19.93	2.21	6.64	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	62.51	6.85	5.14	0.86	0.86	0.86	0.00
bone marrow, adult	10192-103E3	58.71	8.77	4.72	1.35	2.70	0.00	0.67
brain, adult, donor1	10084-102B3	50.23	10.25	2.05	2.05	0.00	2.05	2.05
brain, adult, pool1	10012-101C3	64.03	6.12	3.12	1.89	0.56	1.22	0.67
brain, fetal, pool1	10085-102B4	64.11	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	53.85	3.30	3.96	1.32	0.66	0.66	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	156.28	19.85	7.49	6.62	0.62	1.75	1.37
breast, adult, donor1	10080-102A8	42.30	3.79	2.53	0.63	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	65.17	7.24	3.43	0.89	0.89	0.13	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	108.85	8.97	4.95	2.47	2.16	0.93	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	84.72	8.98	9.67	1.84	3.91	0.23	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	57.13	6.78	4.84	1.94	1.21	0.73	0.48
carcinoid cell line:NCI-H1770	10703-109H1	112.84	4.23	2.82	1.41	0.94	0.47	1.41
carcinoid cell line:NCI-H727	10735-110B6	106.86	8.64	5.58	1.75	0.88	0.88	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	106.48	3.80	3.80	0.95	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	79.85	7.19	5.59	0.53	2.66	0.80	0.53
caudate nucleus - adult, donor10196	10177-103C6	79.44	8.06	4.61	3.45	0.00	0.00	5.76
caudate nucleus, adult, donor10252	10164-103B2	66.60	6.86	2.68	1.17	0.50	0.84	2.01
caudate nucleus, adult, donor10258	10379-105H1	75.65	11.46	6.11	3.82	0.00	0.76	2.29
caudate nucleus, newborn, donor10223	10354-105E3	35.16	2.56	2.20	1.10	1.10	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	96.14	8.74	5.83	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	71.31	11.10	2.56	1.28	1.07	1.28	1.71
cerebellum, adult, pool1	10083-102B2	44.15	8.62	1.38	2.07	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	33.21	8.30	1.66	0.83	0.00	0.00	0.83
cerebral meninges, adult	10188-103D8	42.86	7.31	3.53	1.01	0.25	0.50	1.01
cerebrospinal fluid, donor2	10294-104G6	19.73	2.92	0.73	0.00	0.73	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	130.12	6.90	3.31	0.86	0.58	0.14	0.43
cervical cancer cell line:ME-180	10553-107I4	86.67	8.12	4.31	0.83	0.17	1.16	0.33
cervix, adult, pool1	10013-101C4	85.57	10.81	6.72	1.78	1.26	0.73	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	90.15	5.99	3.07	1.11	1.81	0.70	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	49.64	2.61	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	129.25	6.46	5.59	1.86	1.37	0.25	1.37
choriocarcinoma cell line:SCH	10785-110H2	64.07	2.71	1.97	1.11	0.99	0.25	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	74.47	2.85	2.61	1.42	0.24	1.90	0.95
chorionic membrane cells, donor1	12238-129G6	87.76	8.26	3.13	0.57	1.42	1.42	0.28
chorionic membrane cells, donor2	12239-129G7	130.55	6.66	3.78	1.69	1.19	0.30	0.30
chorionic membrane cells, donor3	12240-129G8	90.12	5.49	6.04	2.20	3.85	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	58.57	1.01	1.01	0.00	3.03	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	69.92	5.76	6.34	0.77	0.58	0.96	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	74.13	7.81	7.18	1.27	0.42	0.84	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	110.42	4.11	2.31	1.28	0.26	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	122.15	5.81	2.42	1.45	1.69	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	136.42	4.28	4.28	1.43	0.81	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	128.38	5.30	2.94	1.18	2.36	0.88	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	111.81	5.99	5.21	1.56	1.30	1.04	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	81.38	5.49	3.20	0.91	5.26	0.91	0.46
clear cell carcinoma cell line:TEN	10636-108I6	106.88	8.33	5.03	1.21	0.69	1.04	0.69
colon carcinoma cell line:CACO-2	10513-107D9	151.01	21.60	15.92	2.93	1.46	0.18	0.37
colon carcinoma cell line:COLO-320	10420-106C6	194.22	16.34	11.40	2.66	0.76	0.76	0.38
colon, adult, donor1	10082-102B1	54.74	3.57	9.52	1.19	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	60.04	8.81	6.46	1.41	0.47	0.59	0.35
colon, fetal, donor1	10070-101I7	40.79	6.80	3.71	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	132.92	22.92	9.17	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	74.36	9.35	8.50	1.27	0.42	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	56.60	12.07	6.64	0.45	0.60	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	68.25	11.70	9.02	0.56	0.71	0.56	0.56
corpus callosum, adult, pool1	10042-101F6	109.24	13.49	6.19	2.21	0.44	0.66	2.10
cruciate ligament, donor2	10295-104G7	29.18	5.67	1.62	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	78.65	4.82	4.01	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	56.40	4.56	2.40	1.68	0.24	0.72	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	88.40	5.05	3.90	1.84	2.76	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	71.80	5.13	4.10	0.26	0.51	1.54	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	62.35	1.20	2.17	3.13	0.72	0.72	1.44
ductus deferens, adult	10196-103E7	74.75	23.42	15.95	0.50	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	80.65	18.72	2.88	1.44	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	90.48	5.89	4.41	1.47	2.94	0.00	0.00
dura mater, adult, donor1	10041-101F5	94.73	10.08	5.95	2.15	0.33	0.99	1.49
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	77.50	2.44	3.55	1.33	0.67	0.89	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	106.18	2.44	3.58	2.58	0.57	2.44	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	55.50	1.85	1.23	1.85	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	41.77	1.82	0.61	0.61	1.51	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	55.57	2.47	0.31	0.93	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	49.91	1.31	0.00	1.31	0.00	1.31	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	154.19	8.38	7.37	3.35	0.00	1.68	3.02
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	94.42	8.52	5.07	0.91	1.09	0.18	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	82.18	4.34	3.06	0.48	2.57	1.29	1.13
epidermoid carcinoma cell line:A431	10426-106D3	73.25	8.89	8.45	1.11	0.44	1.00	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	105.70	3.52	3.19	2.86	1.21	1.65	1.10
epididymis, adult	10197-103E8	76.19	9.00	6.07	1.26	1.05	0.63	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	79.12	3.37	1.60	1.60	1.06	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	71.18	14.16	6.29	1.18	0.39	1.18	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	72.86	4.46	1.44	1.18	1.70	0.92	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	78.74	5.12	3.35	1.48	0.69	0.89	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	69.68	3.14	3.70	2.13	0.56	0.78	0.78
esophagus, adult, pool1	10015-101C6	53.51	10.51	8.81	0.85	0.64	0.74	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	118.85	6.39	3.26	2.50	0.25	1.25	1.00
eye - muscle inferior rectus, donor1	10272-104E2	19.32	0.00	4.83	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	6.31	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	28.28	4.46	2.98	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	22.93	5.73	2.29	3.44	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	16.03	2.91	0.00	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	58.47	13.73	6.86	1.02	1.27	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	57.32	3.21	2.05	1.03	0.77	0.51	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	64.34	3.80	3.32	1.42	1.42	0.95	0.00
frontal lobe, adult, pool1	10040-101F4	78.72	9.66	4.97	3.28	0.56	0.56	1.60
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	104.79	2.40	2.10	3.00	0.90	1.20	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	119.51	7.31	4.30	1.55	0.37	1.19	0.37
gall bladder, adult	10198-103E9	67.36	6.04	2.90	1.45	0.24	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	82.68	8.59	4.29	1.07	0.54	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	62.75	10.08	6.35	1.49	1.12	0.37	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	59.56	3.80	2.11	0.63	1.48	1.06	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	149.12	6.58	3.67	2.90	2.71	0.58	0.19
gastric cancer cell line:AZ521	10549-107H9	125.10	10.49	11.15	2.62	1.31	2.62	1.31
gastric cancer cell line:GSS	10560-108A2	142.78	3.66	7.32	2.75	0.92	0.00	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	100.29	6.85	5.48	0.69	0.69	0.46	0.46
giant cell carcinoma cell line:LU65	10487-107B1	120.02	3.10	2.07	2.52	2.98	0.46	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	100.07	5.46	4.90	1.54	0.56	0.70	1.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	62.35	6.48	3.99	1.25	1.75	0.50	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	83.18	7.71	5.07	1.58	0.74	0.95	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	81.03	8.71	3.37	2.11	0.14	0.70	0.42
glioblastoma cell line:T98G	10485-107A8	102.87	11.26	8.61	1.99	1.66	1.21	0.88
glioma cell line:GI-1	10413-106B8	67.36	11.42	8.49	0.29	0.59	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	73.62	8.02	2.92	0.73	0.00	0.00	1.46
globus pallidus, adult, donor10252	10161-103A8	92.76	11.96	5.86	3.17	0.49	1.46	2.20
globus pallidus, adult, donor10258	10367-105F7	83.52	5.48	4.11	2.74	0.00	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	43.17	2.13	2.13	2.13	0.53	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	141.93	14.68	2.45	4.89	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	10.45	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	63.04	3.20	2.56	0.96	0.96	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	79.43	2.75	2.30	2.30	1.38	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	82.31	2.29	2.29	2.29	0.46	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	77.94	3.22	2.58	0.64	0.00	0.00	1.29
hIPS, biol_rep1	14380-156B6	94.86	4.31	1.44	1.44	0.00	1.44	1.44
hIPS, biol_rep2	14381-156B7	74.76	3.43	1.37	1.37	0.69	2.06	0.69
hIPS, biol_rep3	14382-156B8	75.04	2.21	3.31	3.31	2.21	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	55.46	2.01	4.02	1.72	0.57	0.86	0.29
heart - mitral valve, adult	10205-103F7	54.41	9.87	5.08	2.39	0.00	0.30	0.90
heart - pulmonic valve, adult	10206-103F8	61.45	6.80	2.09	0.78	1.05	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	48.29	3.33	5.00	0.00	0.00	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	63.05	6.94	4.69	0.82	1.22	0.61	0.20
heart, adult, diseased, donor1	10051-101G6	58.34	5.11	4.68	0.43	2.55	0.43	0.00
heart, adult, pool1	10016-101C7	73.59	8.05	3.45	1.38	0.23	0.46	0.69
heart, fetal, pool1	10046-101G1	99.39	11.50	7.50	0.82	0.41	0.62	1.03
hepatic mesenchymal tumor cell line:LI90	10778-110G4	111.99	11.11	6.79	1.23	3.09	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	72.54	3.57	2.38	2.38	0.00	1.19	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	250.05	21.44	19.34	3.76	3.09	1.66	1.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	256.95	25.73	17.24	3.88	3.40	1.58	1.82
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	286.08	25.26	18.39	4.55	3.44	1.52	1.82
hepatoma cell line:Li-7	10484-107A7	82.74	3.89	1.67	0.67	0.78	0.33	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	90.75	3.82	4.02	1.01	0.90	0.70	0.40
hippocampus - adult, donor10196	10169-103B7	64.35	6.62	4.73	2.84	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	70.62	7.96	3.06	1.22	0.82	0.61	2.04
hippocampus, adult, donor10258	10374-105G5	75.19	2.99	3.49	2.49	1.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	41.24	4.58	2.82	0.70	0.00	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	130.61	3.66	6.10	5.49	7.32	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	90.32	3.73	2.55	2.16	3.14	0.79	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	104.35	3.81	3.55	2.79	4.32	2.29	2.79
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	51.88	3.38	8.46	0.00	0.56	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	61.20	3.36	6.71	0.77	14.46	0.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	68.33	6.07	8.73	1.14	0.76	0.38	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	49.05	4.09	2.34	1.17	1.17	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	48.69	1.94	1.94	1.08	0.43	0.00	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	56.72	2.92	2.09	1.67	0.83	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	63.70	4.03	3.55	1.42	0.95	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	67.50	6.27	5.14	0.64	1.45	0.32	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	65.31	4.04	5.39	0.67	1.35	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	68.54	2.97	2.66	1.88	2.66	0.78	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	80.08	5.40	3.93	3.44	9.33	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	58.47	3.49	2.62	1.75	4.36	0.87	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	65.67	8.40	9.55	1.34	1.53	0.95	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	73.70	5.67	5.23	0.87	2.18	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	64.47	5.00	11.99	0.50	5.50	1.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	35.79	2.83	3.96	0.57	0.75	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	43.20	5.91	4.55	1.36	1.82	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.21	4.07	4.39	1.25	2.19	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	50.46	7.02	6.21	1.47	2.78	0.33	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	50.22	4.64	5.23	0.58	1.45	0.58	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	46.03	9.27	8.37	0.60	0.60	0.90	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	77.04	3.14	3.14	1.48	3.51	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	81.59	5.71	2.85	0.86	1.14	1.71	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	114.74	6.12	1.63	3.27	2.86	0.41	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	53.16	3.17	4.58	2.11	1.76	0.70	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	60.50	3.17	5.38	0.95	0.95	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	72.93	5.45	5.75	1.51	0.91	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	42.40	3.10	4.65	0.00	0.52	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	41.84	4.65	3.98	1.99	0.00	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	46.43	3.08	4.10	1.54	0.77	0.00	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	56.75	3.83	4.35	1.28	3.07	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	49.98	1.51	5.30	0.76	2.27	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	63.18	4.37	5.04	1.01	1.34	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	75.11	3.38	3.62	1.45	0.97	0.97	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	77.54	3.57	0.89	0.89	2.23	0.45	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	98.05	3.41	4.88	2.44	2.44	1.95	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	68.15	4.28	7.33	1.22	0.92	0.92	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	185.43	16.27	32.53	6.51	13.01	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	75.79	5.96	14.56	2.32	2.65	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	54.73	1.09	4.93	0.55	1.64	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	47.77	6.15	2.17	1.45	1.09	1.45	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	45.20	2.49	4.27	0.36	0.71	0.36	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	56.09	3.58	4.77	0.00	4.77	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	93.04	5.42	6.50	1.76	0.95	0.27	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	54.42	3.77	3.77	1.89	0.81	0.00	0.00
immature langerhans cells, donor1	11904-125F5	82.57	14.53	11.14	1.94	0.24	0.48	0.48
immature langerhans cells, donor2	11905-125F6	33.27	1.58	5.54	0.79	0.79	1.58	0.00
insula, adult, pool1	10039-101F3	86.49	11.73	7.00	3.69	0.09	1.61	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	53.65	7.15	7.15	0.98	0.00	1.30	0.00
kidney, adult, pool1	10017-101C8	75.30	9.11	4.51	1.70	0.40	0.70	0.30
kidney, fetal, pool1	10045-101F9	89.34	10.82	4.03	1.98	0.35	0.78	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	131.65	6.53	6.39	3.69	0.85	2.13	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	51.84	2.76	4.56	0.28	1.66	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	65.33	2.94	1.47	1.10	0.55	0.55	0.37
left atrium, adult, donor1	10079-102A7	52.85	7.08	3.27	1.63	1.63	0.54	0.00
left ventricle, adult, donor1	10078-102A6	48.54	6.07	2.53	1.52	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	101.78	6.57	4.10	1.64	0.82	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	84.78	10.78	6.11	2.16	3.59	0.36	2.16
leiomyoma cell line:15242A	10570-108B3	118.48	13.04	7.07	2.17	5.98	2.72	1.63
leiomyoma cell line:15425	10571-108B4	83.29	6.31	2.67	1.70	5.58	0.97	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	6.35	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	50.19	2.09	1.05	1.05	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	108.97	7.91	6.38	1.30	0.83	0.47	0.83
liposarcoma cell line:KMLS-1	10782-110G8	87.32	7.97	8.12	0.94	0.62	0.94	0.47
liposarcoma cell line:SW 872	10726-110A6	56.53	4.02	1.58	1.83	0.85	0.37	0.37
liver, adult, pool1	10018-101C9	99.67	16.37	9.89	1.30	1.62	0.49	0.16
liver, fetal, pool1	10086-102B5	37.63	2.82	3.76	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	45.64	4.52	2.48	0.87	0.29	0.44	0.73
locus coeruleus, adult, donor10252	10165-103B3	61.27	7.01	2.21	2.03	0.74	1.11	1.48
locus coeruleus, adult, donor10258	10375-105G6	50.22	8.18	2.82	1.41	0.85	0.56	0.28
locus coeruleus, newborn, donor10223	10362-105F2	33.23	3.36	2.52	0.42	0.84	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	94.94	14.39	10.10	0.42	0.55	0.28	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	82.73	5.52	2.07	4.83	0.00	1.38	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	225.41	15.03	11.60	5.54	3.30	3.43	1.71
lung, adult, pool1	10019-101D1	55.05	5.20	2.72	0.95	0.00	0.47	1.06
lung, fetal, donor1	10068-101I5	131.57	8.56	6.56	1.43	0.29	0.86	1.14
lung, right lower lobe, adult, donor1	10075-102A3	42.61	8.71	4.58	0.46	0.46	0.46	0.46
lymph node, adult, donor1	10077-102A5	43.08	7.57	2.84	0.47	0.95	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	149.26	8.33	10.74	0.66	0.88	0.66	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	121.04	9.81	6.64	1.51	1.81	1.06	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	148.66	3.40	5.10	3.40	1.70	0.00	0.85
mature adipocyte, donor1	12231-129F8	67.49	9.32	4.00	0.44	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	59.77	8.09	5.19	0.62	0.21	0.62	0.42
mature adipocyte, donor3	12233-129G1	53.58	7.11	4.74	1.90	0.24	0.95	0.24
mature adipocyte, donor4	12234-129G2	49.48	12.37	5.53	0.53	0.26	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	191.56	25.49	16.44	1.91	0.48	1.43	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	64.30	2.26	2.26	1.13	1.13	0.00	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	67.31	7.17	2.21	2.39	0.92	0.74	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	61.95	6.35	4.45	2.86	1.59	0.64	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	38.38	4.69	3.84	1.28	0.43	0.85	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	62.61	7.93	3.54	3.38	13.84	1.01	2.03
medial temporal gyrus, adult, donor10252	10156-103A3	59.42	9.55	1.49	1.70	0.42	0.64	2.12
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	63.57	3.85	0.00	1.93	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	0.00	0.00	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	37.33	5.74	2.15	1.79	0.00	0.72	1.44
medulla oblongata - adult, donor10196	10174-103C3	61.00	10.38	3.89	2.60	0.00	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	79.26	8.05	4.33	1.70	0.46	0.77	1.55
medulla oblongata, adult, pool1	10038-101F2	74.93	7.51	4.08	2.12	0.33	0.73	1.47
medulla oblongata, newborn, donor10223	10361-105F1	40.27	3.82	1.74	1.39	1.04	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	142.15	25.24	41.40	1.11	2.21	1.11	0.44
medulloblastoma cell line:ONS-76	10759-110E3	46.46	2.81	1.96	0.37	0.24	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	46.00	3.88	2.59	0.72	0.72	0.14	0.29
melanoma cell line:G-361	10465-106H6	84.15	4.34	3.53	1.09	1.09	1.09	0.00
meningioma cell line:HKBMM	10691-109F7	64.04	2.53	1.09	0.36	2.71	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	96.93	7.93	5.29	1.76	5.29	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	75.69	4.15	1.04	1.04	1.56	0.78	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	94.52	9.21	7.83	1.07	1.53	0.46	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	80.35	12.18	8.91	0.73	1.45	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	62.12	3.31	2.90	0.83	2.07	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	64.62	4.78	2.95	0.56	0.84	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	66.24	3.47	3.66	1.16	1.54	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	83.29	4.86	7.63	1.39	2.08	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	84.44	11.50	11.16	0.51	1.54	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	67.28	6.10	3.22	0.92	0.35	0.46	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	67.25	5.70	4.64	0.40	1.46	0.13	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	71.98	5.27	2.16	0.81	1.62	0.54	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	84.36	3.41	2.56	0.57	0.71	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	63.89	9.22	12.19	0.00	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	72.23	4.70	3.04	1.38	0.83	0.42	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	93.90	8.03	4.54	0.35	1.40	1.05	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	75.75	3.47	1.02	0.41	1.43	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	76.92	2.88	2.88	0.72	0.00	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	58.24	3.62	1.14	1.03	1.03	0.52	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	63.84	3.19	2.28	1.37	1.60	0.23	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	87.27	5.45	2.10	2.10	1.26	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	67.99	3.14	2.24	1.05	1.34	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	79.92	7.09	4.64	0.53	1.23	0.61	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	78.42	2.21	5.89	0.00	1.47	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	80.41	6.87	4.29	0.29	1.43	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	55.99	7.16	5.47	0.42	2.53	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	63.48	4.11	3.20	0.46	0.91	0.46	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	59.85	4.86	3.58	0.26	1.02	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	62.30	4.71	2.88	0.79	1.05	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	62.54	4.93	4.31	1.54	2.16	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	62.13	3.53	3.77	0.94	1.88	0.47	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	66.34	3.72	4.06	1.35	1.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	60.52	6.68	3.54	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	54.68	5.10	4.17	0.46	0.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	70.66	7.21	4.04	0.87	2.60	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	64.03	4.02	2.45	0.45	0.67	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	62.49	4.33	6.25	0.48	1.68	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	71.87	5.87	9.53	1.47	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	60.75	3.36	3.02	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	59.36	4.09	4.50	1.23	0.82	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	66.58	4.30	4.73	0.86	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	90.24	2.73	10.94	0.00	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	57.49	4.55	3.90	1.62	1.95	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	56.74	2.91	1.45	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	76.23	9.06	6.40	0.53	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	57.24	5.72	4.09	0.00	1.64	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	64.92	6.61	3.11	1.17	2.72	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	71.36	2.10	8.39	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	54.64	2.98	6.95	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	4.77	9.53	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	56.92	6.52	3.56	0.00	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	64.58	4.87	10.97	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	70.31	7.60	4.43	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	49.32	6.21	2.41	0.00	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	47.28	8.60	4.30	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	3.99	7.98	0.00	11.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	65.43	3.44	17.22	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	47.67	4.48	5.70	0.41	2.04	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	50.84	3.18	3.18	0.00	2.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	50.11	3.54	2.95	0.00	2.36	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	45.20	2.81	4.99	0.00	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	37.43	8.02	1.34	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	40.21	2.37	3.55	3.55	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	7.70	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	46.12	8.26	4.82	0.69	4.13	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	47.50	2.97	4.45	0.00	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	41.50	2.24	2.24	0.00	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	43.25	5.72	1.27	0.00	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	44.33	4.43	5.24	0.40	0.81	0.81	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	50.15	4.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	41.81	7.60	6.34	1.27	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	69.79	5.46	3.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	76.82	4.52	9.04	4.52	18.08	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	66.72	6.59	5.77	0.82	1.65	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	48.02	4.96	2.98	0.00	0.99	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	47.38	6.17	3.24	0.00	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	51.95	6.11	3.06	1.02	3.06	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	69.63	3.87	3.87	0.77	0.00	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	177.89	4.72	3.07	2.36	1.18	1.65	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	102.86	12.28	4.17	1.85	1.39	1.16	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	4.27	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	44.29	4.42	3.19	0.21	1.64	0.72	0.41
mesothelioma cell line:Mero-25	10850-111F4	80.34	2.72	0.45	1.82	0.68	1.59	0.91
mesothelioma cell line:Mero-41	10851-111F5	116.61	9.05	5.87	1.47	1.47	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	82.15	3.10	3.76	1.11	1.33	0.44	0.44
mesothelioma cell line:Mero-82	10853-111F7	80.16	5.78	3.68	0.79	0.26	0.00	0.79
mesothelioma cell line:Mero-83	10854-111F8	80.00	4.09	2.04	1.02	0.34	0.51	0.34
mesothelioma cell line:Mero-84	10855-111F9	108.95	8.09	4.55	1.77	1.77	3.79	2.02
mesothelioma cell line:Mero-95	10856-111G1	80.13	10.97	6.21	2.69	0.41	0.83	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	86.14	7.29	3.81	1.82	0.83	0.50	0.50
mesothelioma cell line:NCI-H226	10846-111E9	74.57	3.62	3.44	1.09	0.90	0.72	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	85.07	6.66	4.10	0.68	0.85	0.17	0.85
mesothelioma cell line:NCI-H28	10845-111E8	79.65	5.34	4.83	1.78	1.27	1.27	1.78
mesothelioma cell line:No36	10857-111G2	65.57	2.28	0.98	1.96	1.96	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	96.46	9.75	5.69	1.90	2.44	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	48.17	9.02	4.41	1.15	0.19	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	50.43	10.01	3.79	0.98	0.37	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	57.79	10.41	5.74	0.54	0.18	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	47.67	2.94	1.31	0.65	5.88	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	49.59	2.76	2.33	0.00	1.06	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	104.35	7.14	5.30	0.69	0.69	0.92	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	33.68	4.38	4.19	0.19	0.00	0.76	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	92.58	7.02	5.17	1.11	0.55	0.18	0.18
myeloma cell line:PCM6	10474-106I6	80.25	14.83	8.90	0.20	0.79	0.59	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	51.24	3.55	1.52	0.00	0.51	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	85.71	6.08	3.33	0.39	1.18	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	86.13	4.68	2.56	0.45	0.56	0.67	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	79.20	4.85	2.57	0.59	0.88	0.66	0.15
nasal epithelial cells, donor2	12227-129F4	94.39	4.97	3.86	0.55	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	144.71	6.67	11.50	1.61	0.46	0.46	0.46
neuroblastoma cell line:NB-1	10539-107G8	121.04	6.74	4.86	2.62	0.94	0.37	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	65.59	2.32	2.11	0.42	0.84	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	109.02	4.29	6.34	1.12	1.12	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	69.03	2.85	6.64	0.47	1.42	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	63.83	5.23	3.33	0.79	0.95	0.63	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	72.45	8.86	8.45	0.60	0.60	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	67.39	1.91	2.54	0.00	0.64	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	89.17	6.65	4.79	0.80	1.33	1.33	0.00
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	80.33	3.38	3.04	4.23	0.51	1.86	4.23
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	90.46	6.40	2.40	2.40	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	92.98	9.94	6.09	0.00	2.56	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	64.64	8.93	6.31	0.26	4.47	1.05	0.79
nucleus accumbens, adult, pool1	10037-101F1	81.37	11.90	5.72	2.72	0.75	0.75	1.59
occipital cortex - adult, donor10196	10172-103C1	96.84	6.18	6.18	0.00	2.06	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	58.77	9.39	3.49	1.61	0.54	0.54	1.88
occipital cortex, newborn, donor10223	10355-105E4	43.31	4.37	2.91	1.46	0.36	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	63.50	11.55	4.72	1.05	1.57	0.52	1.31
occipital lobe, fetal, donor1	10073-102A1	87.54	6.44	3.43	3.00	0.43	1.72	2.15
occipital pole, adult, pool1	10036-101E9	67.02	8.04	4.81	2.44	0.32	0.55	1.26
olfactory region, adult	10195-103E6	54.83	3.25	0.96	1.72	0.19	0.00	0.96
optic nerve, donor1	10277-104E7	76.04	10.01	6.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	131.34	12.53	9.00	1.82	0.80	0.11	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	134.50	6.73	4.53	2.47	0.69	1.65	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	45.89	2.71	3.05	0.85	2.20	0.68	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	92.52	5.31	4.27	1.85	1.04	0.46	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	72.02	4.12	5.00	0.88	1.18	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	90.63	6.54	4.67	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	100.94	12.09	12.30	1.70	1.06	0.64	1.06
ovary, adult, pool1	10020-101D2	92.68	5.68	2.97	1.14	0.52	0.61	1.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	59.58	3.30	1.83	0.92	2.02	1.65	0.92
pancreas, adult, donor1	10049-101G4	130.75	25.40	16.93	0.00	3.76	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	44.45	2.52	1.40	1.12	0.56	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	79.55	3.24	1.53	1.53	1.70	0.51	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	130.48	6.29	6.13	0.99	0.83	1.82	0.33
paracentral gyrus, adult, pool1	10035-101E8	83.83	10.34	3.57	2.56	0.46	0.64	1.56
parietal cortex, adult, donor10258	10373-105G4	65.33	2.20	4.40	2.20	1.47	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	59.25	9.40	5.64	0.94	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	61.28	5.13	3.14	2.00	0.29	0.57	1.14
parietal lobe, adult, pool1	10034-101E7	84.77	11.63	4.32	2.11	0.26	0.18	1.15
parietal lobe, fetal, donor1	10072-101I9	74.68	3.88	0.97	2.91	0.00	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	40.00	4.49	2.99	0.75	0.75	0.37	1.12
parotid gland, adult	10199-103F1	142.45	36.38	23.43	1.23	1.85	0.00	0.00
penis, adult	10200-103F2	55.32	8.06	4.83	0.54	3.76	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	63.40	0.56	0.37	1.30	1.30	1.49	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	108.25	7.72	5.54	1.75	0.87	0.73	0.87
pineal gland - adult, donor10196	10179-103C8	72.24	18.71	16.13	0.65	0.65	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	100.08	35.53	15.40	2.37	0.00	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	66.47	26.34	18.81	0.63	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	210.45	28.33	10.12	1.01	4.05	2.02	2.02
pituitary gland, adult, donor10252	10162-103A9	249.65	26.06	14.59	1.04	0.52	2.08	1.04
pituitary gland, adult, donor10258	10378-105G9	145.56	17.02	28.94	3.40	0.85	0.85	0.85
placenta, adult, pool1	10021-101D3	116.64	12.36	5.91	1.83	1.72	0.65	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	100.78	7.15	4.50	0.93	1.59	1.06	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	129.34	14.94	7.32	0.78	0.78	0.47	0.62
pons, adult, pool1	10033-101E6	77.46	7.57	3.79	3.27	0.69	0.95	0.86
postcentral gyrus, adult, pool1	10032-101E5	68.69	10.20	4.27	3.05	0.70	0.44	1.05
promyelocytes/myelocytes PMC, donor1	12132-128D8	129.67	6.27	4.18	16.73	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	11.02	5.51	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	66.71	3.93	3.20	1.46	1.02	0.29	0.73
prostate cancer cell line:PC-3	10439-106E7	131.77	6.53	4.36	3.45	1.63	0.91	1.27
prostate, adult, pool1	10022-101D4	66.39	7.53	4.35	1.54	0.45	0.63	0.54
putamen, adult, donor10196	10176-103C5	73.65	8.03	3.07	2.60	0.71	1.89	1.42
putamen, adult, donor10252	10152-102I8	64.70	11.76	5.88	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	76.50	3.28	2.19	4.37	0.00	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	72.97	6.77	3.87	2.17	0.72	0.97	1.45
putamen, newborn, donor10223	10365-105F5	30.74	1.50	1.50	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	103.57	9.60	5.24	1.16	0.29	0.87	0.00
rectum, fetal, donor1	10067-101I4	72.33	11.13	4.17	1.39	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	132.07	13.57	6.36	3.39	3.18	2.33	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	79.11	4.97	1.24	0.41	0.83	0.41	1.24
retina, adult, pool1	10030-101E3	70.97	16.30	7.55	2.09	0.60	0.40	0.89
retinoblastoma cell line:Y79	10475-106I7	74.30	18.45	28.58	0.78	1.04	0.00	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	77.83	6.02	3.81	0.98	0.74	1.35	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	175.75	14.34	10.97	4.22	0.84	1.69	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	67.45	5.30	5.30	0.00	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	47.42	4.21	8.25	0.32	0.97	0.16	0.00
salivary acinar cells, donor2	11772-123I8	53.70	4.41	5.37	0.55	1.24	0.69	0.28
salivary acinar cells, donor3	11773-123I9	36.41	3.31	3.31	0.00	1.99	0.66	0.00
salivary gland, adult, pool1	10093-102C3	156.14	20.59	11.44	2.29	0.57	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	40.72	2.02	1.85	0.42	0.34	0.42	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	39.03	1.88	2.12	0.82	0.24	0.35	0.00
seminal vesicle, adult	10201-103F3	68.78	20.10	10.05	1.06	2.12	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	153.29	18.71	15.55	3.16	5.10	1.21	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	91.85	3.52	4.78	0.75	2.52	1.76	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	98.35	5.02	2.01	0.00	2.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	137.01	6.85	5.78	2.96	3.09	1.21	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	55.82	3.54	4.20	0.66	0.44	0.99	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	131.09	13.16	10.58	2.19	1.03	1.55	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	26.95	1.42	1.42	1.42	2.13	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	53.25	7.56	3.48	1.08	0.00	0.36	0.48
skeletal muscle, fetal, donor1	10066-101I3	74.37	11.06	8.04	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	6.79	20.36	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	99.73	13.89	5.05	0.00	3.16	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	82.38	2.33	2.33	2.33	0.67	1.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	87.00	1.58	5.36	1.58	0.63	1.26	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	42.21	1.93	1.93	1.73	0.96	0.58	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	147.36	6.10	10.05	3.63	1.48	0.99	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	147.02	38.12	70.93	0.80	2.25	0.32	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	117.89	10.46	8.50	0.65	1.09	1.53	1.53
small intestine, adult, pool1	10024-101D6	97.35	16.72	9.32	1.67	0.72	0.60	0.24
small intestine, fetal, donor1	10064-101I1	71.50	7.37	5.16	0.49	0.74	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	119.51	13.85	5.64	1.03	5.64	2.05	1.03
smooth muscle, adult, pool1	10048-101G3	53.24	9.30	3.36	0.52	1.55	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	144.20	20.64	12.33	0.27	0.54	0.00	0.80
spinal cord - adult, donor10196	10181-103D1	57.58	9.64	2.98	1.38	2.06	0.92	1.38
spinal cord, adult, donor10252	10159-103A6	69.00	6.70	5.13	1.18	0.39	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	65.03	1.38	2.08	2.08	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	91.48	6.71	4.88	0.61	0.61	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	54.65	6.43	3.67	0.00	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	87.97	8.51	4.93	0.45	1.05	0.60	0.15
spleen, adult, pool1	10025-101D7	64.10	7.93	4.52	0.55	0.44	0.22	0.11
spleen, fetal, pool1	10044-101F8	68.41	7.71	3.65	1.11	0.56	0.40	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	69.56	6.62	3.73	1.97	1.35	0.41	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	146.20	7.97	6.84	2.85	1.14	1.52	1.71
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	77.23	5.94	6.29	0.70	2.80	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	64.11	3.52	0.39	0.39	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	195.51	7.88	7.09	4.28	1.35	0.34	0.90
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	112.25	5.51	3.39	5.93	2.12	0.85	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	90.96	12.69	10.58	0.42	0.85	0.42	0.42
stomach, fetal, donor1	10062-101H8	68.35	8.54	3.20	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	102.54	13.10	14.81	1.71	1.71	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	75.60	10.59	3.12	1.25	1.87	0.00	2.70
substantia nigra, adult, donor10258	10371-105G2	67.24	4.14	2.07	3.10	1.55	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	35.33	2.12	4.95	1.41	0.00	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	68.78	6.42	2.52	2.29	0.69	0.69	1.60
temporal lobe, adult, pool1	10031-101E4	72.31	9.32	4.15	3.05	0.42	0.34	1.78
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	98.29	4.99	2.14	2.85	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	89.23	4.83	3.96	0.88	0.88	0.88	0.44
tenocyte, donor1	11763-123H8	103.33	8.73	7.33	0.70	7.33	0.70	0.00
tenocyte, donor2	11765-123I1	57.23	3.43	3.43	0.38	2.67	0.00	0.38
tenocyte, donor3	11768-123I4	84.51	4.82	3.34	2.22	3.34	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	110.30	4.08	5.27	1.87	0.51	0.34	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	80.47	9.40	10.17	1.23	1.23	0.46	0.92
teratocarcinoma cell line:PA-1	10807-111A6	92.52	2.94	3.87	0.62	0.62	0.31	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	70.20	6.22	3.55	0.76	0.76	0.89	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	99.46	3.03	4.54	2.27	0.00	0.00	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	42.21	2.29	2.73	0.65	0.44	0.11	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	67.75	0.98	3.26	1.30	2.93	0.33	0.98
testis, adult, pool1	10026-101D8	81.60	6.44	3.65	2.79	1.72	3.44	1.40
testis, adult, pool2	10096-102C6	108.26	5.41	4.96	3.16	2.71	4.51	2.26
thalamus - adult, donor10196	10168-103B6	85.01	5.52	4.42	2.21	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	80.17	9.85	4.06	1.41	0.47	0.78	2.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	98.54	3.08	1.54	0.00	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	36.89	4.12	2.31	1.15	0.66	0.49	0.66
thalamus, newborn, donor10223	10366-105F6	30.49	5.18	4.60	2.30	0.00	0.00	0.58
throat, adult	10209-103G2	53.93	10.24	5.49	0.50	0.00	0.00	0.50
throat, fetal, donor1	10061-101H7	70.08	11.58	5.48	1.22	1.22	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	64.39	8.15	5.37	3.18	0.79	0.79	1.39
thymus, adult, pool1	10027-101D9	92.75	4.57	2.19	0.50	0.60	0.30	0.40
thymus, fetal, pool1	10043-101F7	92.16	5.20	2.18	1.66	0.52	0.42	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	92.94	6.91	5.32	0.66	0.80	0.27	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	84.51	4.05	4.19	0.84	0.70	0.28	0.56
thyroid, adult, pool1	10028-101E1	89.95	11.48	7.00	1.96	0.47	1.12	0.93
thyroid, fetal, donor1	10060-101H6	71.98	10.28	5.27	1.05	1.58	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	12.32	12.32	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	52.10	7.91	9.07	0.23	1.16	0.70	0.47
tongue, fetal, donor1	10059-101H5	76.45	9.46	5.12	0.39	0.79	0.39	0.39
tonsil, adult, pool1	10047-101G2	104.78	18.23	15.43	1.90	0.50	0.90	0.80
trachea, adult, pool1	10029-101E2	86.87	13.91	6.22	1.23	0.41	0.65	0.25
trachea, fetal, donor1	10058-101H4	85.40	11.54	1.92	1.15	1.15	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	96.36	8.50	6.38	2.13	0.35	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	123.00	14.18	9.52	1.52	0.81	1.01	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	113.75	8.77	4.23	1.25	1.72	0.47	0.63
tridermal teratoma cell line:HGRT	10694-109G1	87.52	1.90	5.71	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	75.76	7.28	8.30	0.76	0.51	0.42	0.17
umbilical cord, fetal, donor1	10057-101H3	54.25	8.35	2.09	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	94.36	9.73	4.78	1.19	0.17	0.17	1.19
uterus, fetal, donor1	10055-101H1	82.42	10.24	5.63	0.00	2.05	0.51	1.02
vagina, adult	10204-103F6	45.23	5.17	2.58	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	50.20	5.04	3.73	0.00	0.66	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	75.04	4.81	3.74	1.87	1.07	1.34	0.80

Property "Nearest transcripts" (as page type) with input value "AK315508:84 AK023201:100 ENST00000497674.5:112 ENST00000493692.5:112 ENST00000234160.5:112 NM_015530.5:112 AK293640:112 AK225810:112 AK023082:113 ENST00000455067.5:116 ENST00000454751.5:126 AK298020:131 BC007770:151 BC001408:158 ENST00000442798.5:180 AK296698:180 AK027349:186 AB528359:196 DQ895965:198 DQ892715:198 CU675801:199 KJ893507:199 ENST00000497928.1:292" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.